Trusted By The Companies Pioneering What’s Next

The most efficient way to
raise awareness and capital
Our presenter package is optimized to amplify your startup.
Share your story on our stage, connect with investors, and
generate excitement beyond the event with our digital media.
blog
1 full registration included for the selected Summit
blog
9 minute onstage presentation with your slide deck
blog
Curated meeting opportunities to connect with investors
blog
Digital media assets and social media promotion post-event
Now Includes
Funding Fast Track
LSI's Presenter offering is now part of an exclusive, limited-
capacity package with new curated opportunities to get in front of
the right investors throughout the summit
What's Included?
Based on capacity, the activities below are available ONLY for Funding Fast Track program members.
  • tick
    9-minute on-stage presentation
  • tick
    Full media package with your recording for fundraising
  • tick
    Small-group breakfasts with investors, curated by LSI
  • tick
    Exclusive wine tasting event to meet investors at roundtables
  • tick
    Priority invitation to the CEO-only dinner (where applicable)
  • tick
    Company featured in our investor scouting report ahead of LSI
  • tick
    Coming soon: two-way opt-in warm intros from the LSI team
Apply for
Funding Fast Track
Now, in addition to the 9-minute presentation, we're offering select startups a limited-capacity package built to get you in front of the right investors, and keep you there.
Submit your application today and receive a decision within 48 hours.
March 16-20, 2026
Main Speaking and Partnering Days on March 17, 18, 19
"I owe a debt of gratitude to LSI on the path to get us to our monumental financing round. I was introduced to our first lead investor at LSI Europe. The opportunity given he represented a prominent US VC firm."
paul mead
Paul Mead
CEO, CorFlow
"LSI offered an unparalleled chance to engage directly with HERAN Partners, [who became] our lead investor. This personal connection laid the foundation for a strong partnership that played a pivotal role in successfully closing our round."
paul mead
Michael Ebner
CEO, Hypervision Surgical
Presenter Successes
Companies like Vektor
Medical close funding by
presenting at our summits
Vektor Medical, a company advancing care for arrhythmia patients
by unlocking insights contained in a standard ECG, met TVM
Capital and Solas Bioventures through their presentation. The
funds went on to co-lead Vektor’s $16M Series A financing.
Apply to Present at LSI USA ‘26 Who Attends LSI?
summit
Investor perspectives
Are you raising capital?
LSI summits are the can’t-
miss place to present
There’s nothing that compares to telling your story in-person.
Hear from Nick Pachuda of Precision Life Science Partners on why
he and his team recommend that all medtech and healthtech
startups present at LSI summits.
Apply to Present at LSI USA ‘26 Who Attends LSI?
summit
See the leaders confirmed
to attend LSI USA ‘26
Industry-leading executives from emerging companies,
venture capital and private equity firms, family offices,
investment banks, global strategics, and more.
Apply to Present at LSI USA ‘26
  • Michael Mahoney
    Michael Mahoney

    Chairman & CEO

    Boston Scientific

    Peter Hebert
    Peter Hebert

    Managing Partner, Co-Founder

    Lux Capital

    Alan Cohen
    Alan Cohen

    General Partner

    DCVC Management

    Ashley McEvoy
    Ashley McEvoy

    CEO

    Insulet

    Peter Slavin
    Peter Slavin

    President & CEO

    Cedars-Sinai Medical Center and Health System

    Chris Coburn
    Chris Coburn

    Chief Innovation Officer

    Mass General Brigham

  • Katie Szyman
    Katie Szyman

    CEO

    Masimo

    Duke Rohlen
    Duke Rohlen

    CEO

    Ajax Health

    Josh Makower
    Josh Makower

    Director & Co-Founder, Stanford Byers Center for Biodesign

    Venture Partner, Sofinnova Partners

    Philip Rackliffe
    Philip Rackliffe

    President & CEO

    GE HealthCare

    Peter Shagory
    Peter Shagory

    Executive Vice President, Strategy and Corporate Development

    CONMED

    Chris Eso
    Chris Eso

    VP, M&A, Strategy & Portfolio Managment

    Medtronic

  • Amy Salzhauer
    Amy Salzhauer

    Founder and Managing Partner

    Good Growth Capital

    Catherine Mohr
    Catherine Mohr

    President

    Intuitive

    Armen Vidian
    Armen Vidian

    Founder & Managing Partner

    Recode Ventures

    William Dai
    William Dai

    Founding Managing Partner

    ShangBay Capital

    Champ Davis
    Champ Davis

    Chief Operating Officer

    Cordis

    Sonal Patel
    Sonal Patel

    Vice President, Business Development Strategy & Ventures

    Zimmer Biomet Holdings Inc

  • Kyle Dempsey
    Kyle Dempsey

    Partner

    MVM Partners

    Biren Mehta
    Biren Mehta

    VP, Venture Investments

    Johnson & Johnson

    Jay Watkins
    Jay Watkins

    Co-Chair & Partner

    Sonder Capital

    JD Friedland
    JD Friedland

    Managing Director, Ventures

    Cleveland Clinic

    Greg Madden
    Greg Madden

    Managing Partner

    SV Health Investors

    Dennis McWilliams
    Dennis McWilliams

    Partner

    SANTÉ

  • Juan-Pablo Mas
    Juan-Pablo Mas

    Partner

    Action Potential VC

    Debbie Lin
    Debbie Lin

    Venture Partner

    T.Rx Capital

    Gerry Brunk
    Gerry Brunk

    Managing Director

    Lumira Ventures

    Dr. Michael R. Jaff
    Dr. Michael R. Jaff

    Chief Medical Officer & Vice President, Peripheral Interventions

    Boston Scientific

    Frederik Groenewegen
    Frederik Groenewegen

    General Partner

    415 Capital

    Scott Steever
    Scott Steever

    Vice President

    RC Capital

  • Ittai Harel
    Ittai Harel

    Managing General Partner

    Pitango Venture Capital

    Anne Osdoit
    Anne Osdoit

    Partner

    Sofinnova Partners

    Erich Wolff
    Erich Wolff

    Executive Vice President, Strategy & Corporate Development

    QuidelOrtho

    Connor Landgraf
    Connor Landgraf

    Co-founder & Chief Executive Officer

    Eko Health

    Jason Bellet
    Jason Bellet

    Co-founder & Chief Business Officer

    Eko Health

    Mark Deem
    Mark Deem

    Operating Partner

    Lightstone Ventures

  • Bennett Blau
    Bennett Blau

    Senior Managing Director, Investment Banking

    Evercore

    Dave Adair
    Dave Adair

    Managing Partner & Co-Founder

    Solas BioVentures

    Colin Morrison
    Colin Morrison

    Senior Director of Venture Capital

    Boston Scientific

    Addie Harris
    Addie Harris

    Executive In Residence

    1955 Capital

    Douglas Solomon
    Douglas Solomon

    Managing Director

    JP Morgan

    Christopher Cleary
    Christopher Cleary

    CEO

    Biomergence Capital LLC

  • Alexander Marcantonio
    Alexander Marcantonio

    Managing Director

    Madryn Asset Management

    Greg Garfield
    Greg Garfield

    Senior Managing Director

    KCK Medtech

    Daniel Gottlieb
    Daniel Gottlieb

    Director

    Broadview Ventures

    Kevin Chu
    Kevin Chu

    Healthcare Venture Capital

    F-Prime Capital

    Matthew Vessa
    Matthew Vessa

    Vice President

    Hologic

    Colin Tan
    Colin Tan

    Investment Director

    Coronet Ventures

  • Craig Smith
    Craig Smith

    Senior Director, Venture Capital

    Boston Scientific

    Sandeep Konam
    Sandeep Konam

    Co-Founder

    Abridge

    David Prim
    David Prim

    Principal

    Broadview Ventures

    Shai Policker
    Shai Policker

    Managing Partner and CEO

    Edge Medical Ventures

    Ed Rubin
    Ed Rubin

    Leader, Gore Ventures

    W.L. Gore & Associates

    Ashley Friedman
    Ashley Friedman

    Managing Director

    Signet Healthcare Partners

  • Chris Japp
    Chris Japp

    Head of Board

    Tramway Ventures

    Kevin Rocco
    Kevin Rocco

    Partner

    Neovate Capital Partners

    Robert King
    Robert King

    Partner

    1540 Ventures

    Gal Noyman Veksler
    Gal Noyman Veksler

    Partner

    LionBird

    Craig Matturro
    Craig Matturro

    Principal

    1315 Capital

    Mike Huiras
    Mike Huiras

    SVP Global Sales

    Aptyx

  • Kinshuk Kocher
    Kinshuk Kocher

    Investment Principal

    Cedars-Sinai Technology Ventures

    Adam Caplan
    Adam Caplan

    Neurotech Investor

    Jumpspace Ventures

    Amanda DePalma
    Amanda DePalma

    SVP, Ultrasound Global Marketing

    Siemens Healthineers

    Liliane Chamas
    Liliane Chamas

    Health Tech Principal

    Oxford Science Enterprises

    Steph Scott
    Steph Scott

    Vice President

    Questa Capital Management

    Tyler Wanke
    Tyler Wanke

    Investor & CEO

    Wanke Family Office/MadSci

  • Andy McGibbon
    Andy McGibbon

    Head of Strategy - US

    Vitestro

    Koen van Breugel
    Koen van Breugel

    Investment Director

    Coronet Ventures

    Jason Wolfe
    Jason Wolfe

    Business Leader - Gore Ventures (Sr Vice President)

    W.L. Gore and Associates

    Nick Pachuda
    Nick Pachuda

    Innovation & New Ventures

    Precision Life Science Partners

    Kevin Schimelfenig
    Kevin Schimelfenig

    Founder and Managing Partner of McGeever, CEO and Founder SalesForce4Hire A McGeever Family Office Company

    The McGeever Family Office

    Chris Bingham
    Chris Bingham

    VP Global Marketing & Strategy

    Cordis

  • Jason Meyer
    Jason Meyer

    General Partner

    Waterston Capital

    Will Glass
    Will Glass

    Partner

    Perella Weinberg Partners

    Tamir Meiri
    Tamir Meiri

    Principal, Venture Investments

    Johnson & Johnson

    Maybelle Jordan
    Maybelle Jordan

    Chief Strategy Officer

    Deerfield Catalyst

    Justin Montellese
    Justin Montellese

    Senior Director Corporate Development (M&A and Strategic Investments)

    Hologic

    Julien Brohan
    Julien Brohan

    Director, Medtech Ventures

    Cedars-Sinai Technology Ventures

  • Heather Roxborough
    Heather Roxborough

    Partner

    Oxford Science Entreprises

    Tiffany Wilson
    Tiffany Wilson

    President & CEO

    University City Science Center

    Yoichi Omae
    Yoichi Omae

    Director, Business Development

    Asahi Intecc USA

    Joshua Eckelberry
    Joshua Eckelberry

    Principal

    Solas BioVentures

    Paul Slosar
    Paul Slosar

    Partner

    46 Venture Capital

    Shailendra Mahajan
    Shailendra Mahajan

    Managing Director

    Wave Crest Securities

  • Karim Maasarani
    Karim Maasarani

    Principal

    Eckuity Capital

    Nirav Dalal
    Nirav Dalal

    Divisional Vice President, Global Data Science & Analytics

    Abbott

    Damé Medarski
    Damé Medarski

    COO & Co-Founder

    GS Capital Connect

    Ayal Ronen
    Ayal Ronen

    Chief Business Officer

    FreeMind Investments

    Kristien Esser
    Kristien Esser

    CEO

    GS Capital Connect

    Robert Abrams
    Robert Abrams

    General Manager- Global Business Development

    Kaneka North America

  • Marc Gliner
    Marc Gliner

    Managing Director

    Haventure

    Zhou Yu
    Zhou Yu

    Director

    Canon Medical Research USA

    Mishone Donelson
    Mishone Donelson

    Sr. Managing Director, Head of Life Sciences

    Horizon Technology Finance

    Heath Naquin
    Heath Naquin

    VP Government & Capital Engagement

    University City Science Center

    Scott Klein
    Scott Klein

    CEO

    HelpWear

    Sarah van de Graaf
    Sarah van de Graaf

    Director, Strategic Alliances

    dsm-firmenich

  • Douwe van den Brink
    Douwe van den Brink

    Chief Strategy Officer

    Natus

    Amie Borgstrom
    Amie Borgstrom

    CEO & Founder

    Borgstrom Consulting Group

    Lewis Tepper
    Lewis Tepper

    Principal

    Aston Partners

    Jennifer Robertson
    Jennifer Robertson

    Vice President

    Canon Medical Research USA

    Momoka Onoda
    Momoka Onoda

    Manager, Venture Investments

    Terumo Americas Holdings

    Rinda Sama
    Rinda Sama

    CEO

    Spiro Medical

  • Surendar Magar
    Surendar Magar

    CEO

    LifeSignals

    Cary Hagan
    Cary Hagan

    President & CEO

    Intrinsic Therapeutics

    Sasha Banjac
    Sasha Banjac

    CEO & Founder

    Pulsli

    Codi Gharagouzloo
    Codi Gharagouzloo

    CSO

    Imaginostics

    Katie Weimer
    Katie Weimer

    CEO & Co-founder

    GenesisTissue

    Tim Gleeson
    Tim Gleeson

    CEO and Board Member

    BRIJ Medical

  • Lara Zibners
    Lara Zibners

    Co-Founder & Chairman

    Calla Lily Clinical Care

    Nader Sadrzadeh
    Nader Sadrzadeh

    Founder & CEO

    Deepsight Technology

    David Constantine
    David Constantine

    CEO

    Juniper Biomedical

    Martin Stenfeldt
    Martin Stenfeldt

    CEO

    UNEEG Medical

    Dimitri Sokolov
    Dimitri Sokolov

    CEO

    Spiro Robotics

    Rob Krummen
    Rob Krummen

    CEO

    Vektor Medical

  • Patryk Kania
    Patryk Kania

    CEO and President

    Field Orthopaedics

    Stuart Simpson
    Stuart Simpson

    CEO

    THINK Surgical

    Olivier Delporte
    Olivier Delporte

    CEO

    SamanTree Medical

    John Wong
    John Wong

    Co-Founder and CEO

    Fluid Biomed

    Peter Vranes
    Peter Vranes

    CEO

    Nutromics

    Elizabeth Hoff
    Elizabeth Hoff

    Board Member

    Somavac Medical Solutions

  • Jennifer Fried
    Jennifer Fried

    CEO

    Flow Medical

    Marcin Golebicki
    Marcin Golebicki

    CEO

    EP Solutions

    William "Bill" Harrity, M.D.
    William "Bill" Harrity, M.D.

    Chief Medical Officer and Co-Founder

    AutoMedicus

    Randy Hubbell
    Randy Hubbell

    President & CEO

    Solaris Endovascular

    Ray Liu
    Ray Liu

    CEO & Co-Founder

    Vena Vitals

    John Santini
    John Santini

    President & CEO

    Vergent Bioscience

  • Jochen Reinöhl
    Jochen Reinöhl

    CEO

    Coramaze Technologies

    Leo Smit
    Leo Smit

    CEO

    Hy2Care

    Justin Anderson
    Justin Anderson

    CEO

    Tensor Surgical

    Vijit Sabnis
    Vijit Sabnis

    Co-Founder

    Adaptyx Biosciences

    Peter Fischer
    Peter Fischer

    CEO

    InkSpace Imaging

    Upma Sharma
    Upma Sharma

    President & CEO

    Arsenal Medical

  • Jim O'Connor
    Jim O'Connor

    General Counsel & Chief Financial Officer

    Axena Health

    Britton Garrett
    Britton Garrett

    CEO

    IO Urology

    Rhonda Rhyne
    Rhonda Rhyne

    CEO

    Prevencio

    Richard Vincent
    Richard Vincent

    CEO

    FundamentalVR

    Sujit Dike
    Sujit Dike

    CEO

    Gyder Surgical

    Brad Hauser
    Brad Hauser

    CEO

    Autonomix Medical

  • Dawn Bitz
    Dawn Bitz

    President

    Lazzaro Medical

    Jeff Luber
    Jeff Luber

    CEO

    Clairity

    Ted Belleza
    Ted Belleza

    CEO

    URO - 1

    John H. Chung
    John H. Chung

    Co-Founder & CEO

    Aposture Surgical

    James Grosvenor
    James Grosvenor

    VP of Global Operations

    Anaut

    Firas Al-Ali M.D.
    Firas Al-Ali M.D.

    Founder and CEO

    CygnusMed

  • Shiva Sharareh
    Shiva Sharareh

    CEO

    Rekovar

    Lloyd Diamond
    Lloyd Diamond

    CEO

    Nitinotes

    Bart Bandy
    Bart Bandy

    CEO

    Solenic Medical

    Patricia Buehler
    Patricia Buehler

    CEO & Founder

    Osheru

    Toufic Kachaamy
    Toufic Kachaamy

    Founder

    EndoInnovate

    Ilan Uchitel
    Ilan Uchitel

    CEO & Co-Founder

    CAPS Medical

  • Solveig Johannessen
    Solveig Johannessen

    CEO

    Dova Health Intelligence

    Saravana Kumar
    Saravana Kumar

    President & CEO

    4C Medical

    Regina Atim
    Regina Atim

    Founder

    Clinicians Touch Allyve

    Kristopher Carver
    Kristopher Carver

    Venture Capital

    Boston Scientific

    Eugene Daneshvar
    Eugene Daneshvar

    NeuroTech Patent Attorney

    Black Swan Intellectual Property

    Kjartan Thorsson
    Kjartan Thorsson

    CEO

    Prescriby

  • Cynthia Perazzo
    Cynthia Perazzo

    Co-Founder and CEO

    Sovato

    Diane Bouis
    Diane Bouis

    Board Member

    BioMEMS

    Denise Steinbring
    Denise Steinbring

    Chief Marketing Officer

    Biomed Simulation

    Nico Weigand
    Nico Weigand

    Co-Founder

    Symphera

    Alan Lucas
    Alan Lucas

    Director

    enlightenVue

    Chris Darland
    Chris Darland

    CEO

    Peerbridge Health

  • Guelay Bilen-Rosas
    Guelay Bilen-Rosas

    CEO

    AyrFlo innovation Labs

    Cody Simmons
    Cody Simmons

    CEO

    DermaSensor

    Per Langoe
    Per Langoe

    CEO

    GT Medical Technologies

    Moises Barbera Ramos
    Moises Barbera Ramos

    Founder & CEO

    Drill Surgeries

    Alex Jiao
    Alex Jiao

    CEO

    Scout Health

    Connor Barth
    Connor Barth

    CEO

    Trace Biosciences

  • Gabriele Niederauer
    Gabriele Niederauer

    CEO

    Freyya

    Oliver Piepenstock
    Oliver Piepenstock

    CEO & Co-Founder

    Noah Labs

    Joana Cartocci
    Joana Cartocci

    CEO

    Robeaute

    Yossi Bar
    Yossi Bar

    CEO

    LEM Surgical

    Timothy Blair
    Timothy Blair

    President

    iChor Vascular

    Lawrence Buchan
    Lawrence Buchan

    CEO

    Arbutus Medical

  • Victor Gura
    Victor Gura

    CEO

    Wearable Artificial Organs

    Henry (Chip) Appelbaum
    Henry (Chip) Appelbaum

    President & CEO

    Novian Health

    James Dacombe
    James Dacombe

    CEO

    CoMind

    Elsa Abruzzo
    Elsa Abruzzo

    CEO

    Anuncia Medical

    Filip Peters
    Filip Peters

    CEO

    Acorai

    Donghee Kim
    Donghee Kim

    CEO

    LN Robotics

  • Peymon Ghazi
    Peymon Ghazi

    CEO

    MALCOVA

    Christopher Landon
    Christopher Landon

    CEO

    Natus Neuro

    Antony Odell
    Antony Odell

    CEO

    Echopoint Medical

    Nathan Friedman
    Nathan Friedman

    CEO

    HemaSense

    Chris Neil
    Chris Neil

    Partner and Co-Founder

    MedTech Advantage Fund

    Mohammad Abedin-Nasab
    Mohammad Abedin-Nasab

    Founder & CEO

    Robossis

  • Ben Holmes
    Ben Holmes

    CEO

    NANOCHON

    Richard Hanbury
    Richard Hanbury

    CEO

    Sana Health

    Ian Lewis
    Ian Lewis

    Founder & CEO

    Rapid Infection Diagnostics

    Gregory Fischer, PhD
    Gregory Fischer, PhD

    Founder & CEO

    AiM Medical Robotics

    Tarek Makansi
    Tarek Makansi

    CEO and CTO

    StimAire

    Eldrick Millares
    Eldrick Millares

    Cofounder, CEO

    Illuminant Surgical

  • Robert Neusner
    Robert Neusner

    President & COO

    BMI OrganBank

    Michael Webb
    Michael Webb

    President & CEO

    Epion Therapeutics

    Westbrook Weaver
    Westbrook Weaver

    CEO

    Tempo Therapeutics

    Pawel Soluch
    Pawel Soluch

    CEO

    Spinally

    Rafael J. Veraza
    Rafael J. Veraza

    CEO & President

    Vascular Perfusion Solutions

    Finbar Dolan
    Finbar Dolan

    CEO

    Versono Medical

  • Olivier Taelman
    Olivier Taelman

    CEO

    Nyxoah

    Gopal K. Chopra
    Gopal K. Chopra

    Co-CEO

    CDX Medical Technologies

    Dr. Yeshwanth Pulijala
    Dr. Yeshwanth Pulijala

    Founder & CEO

    Scalpel

    Christopher Carlton
    Christopher Carlton

    Chairman, Chief Executive Officer and Co-Founder

    Accure Acne

    Malcolm Hebblewhite
    Malcolm Hebblewhite

    President

    Atmo Biosciences

    Karim Aly
    Karim Aly

    CEO

    Noze

  • Christopher Haig
    Christopher Haig

    Co-Founder/Chief Executive Officer

    Efemoral Medical

    Marc Zemel
    Marc Zemel

    CEO

    Retia Medical

    Raimundo Sierra
    Raimundo Sierra

    CEO & Co-Founder

    VirtaMed

    Frederik Ceyssens
    Frederik Ceyssens

    co-founder & CEO

    Revision Implant

    Jeffrey Halbrecht, MD.
    Jeffrey Halbrecht, MD.

    Founder & CEO

    ZKR Orthopedics

    Pieter Wijffels
    Pieter Wijffels

    Venture Partner

    NLC Health Ventures

  • Katya Sverdlov
    Katya Sverdlov

    CEO

    JelikaLite

    Quan Ni
    Quan Ni

    President and CEO

    Restora Medical

    Evan Luxon
    Evan Luxon

    Co-Founder & CEO

    Centese

    Jason Y K Chan
    Jason Y K Chan

    Co - Founder and Chief of Clinical Development

    Agilis Robotics

    Sanjeev Bhatia
    Sanjeev Bhatia

    CEO & Co-Founder

    Joint Preservation Innovations

    Conner Herman
    Conner Herman

    Founder & CEO

    Percy

  • Dirk Coeman
    Dirk Coeman

    MD, CEO

    Valeb

    Haariss Ilyas
    Haariss Ilyas

    Chief Medical Officer

    FoxEyes

    Raj Shah
    Raj Shah

    CEO

    GuideAI Health

    Robert F. Wilson, MD
    Robert F. Wilson, MD

    CEO

    Egg Medical

    Umaima Ahmad
    Umaima Ahmad

    CEO, Co-founder

    52 North Health

    James A. Bowman
    James A. Bowman

    CEO

    Purgo Surgical

  • Mark Pacyna
    Mark Pacyna

    CEO

    Reprieve Cardiovascular

    Jesse Wheeler, PhD
    Jesse Wheeler, PhD

    Chief Operations Officer

    Aurenar

    Derrick Woodard
    Derrick Woodard

    Investment Banker

    RBC Capital Markets, LLC

    Robert Crawford
    Robert Crawford

    Senior Director, Sales and Marketing

    Micro Systems Technologies

    Christine Horton
    Christine Horton

    CEO

    Visura Technologies

    Andrew Glass
    Andrew Glass

    CEO

    Vivasure Medical

  • Pat Thitipattakul
    Pat Thitipattakul

    Managing Partner

    Disrupt Health Impact Fund

    Ann Gaddy
    Ann Gaddy

    Managing Director

    BioPacific Investors, Inc.

    Michael Nilo
    Michael Nilo

    President and Principal Consultant

    Nilo Medical Consulting Group

    Weronika Michaluk
    Weronika Michaluk

    MedTech Practice Lead

    HTD Health

    John Lanzafame
    John Lanzafame

    Business Development, Medical Devices

    Applus+ Laboratories

    Patrick O'Donnell
    Patrick O'Donnell

    President & CEO

    NanoHive Medical LLC

  • Lars Yang
    Lars Yang

    Co-founder

    magAssist

    Alonzo Sexton
    Alonzo Sexton

    CEO, Founder

    NCight

    Anthony Carnemolla
    Anthony Carnemolla

    CEO/Co-Founder

    Lentek Surgical

    Trevor McCaw
    Trevor McCaw

    CEO

    Ripple Medical

    Will Mauldin
    Will Mauldin

    CEO

    RIVANNA

    Robert Souza
    Robert Souza

    Vice President, MedTech Partnering

    Tecan

  • Scott Huennekens
    Scott Huennekens

    Executive Chairman

    Front Foot Ventures

    Anna Hildebrand
    Anna Hildebrand

    Analyst

    IAG Capital Partners

    Patrick Morris
    Patrick Morris

    Chief Operating Officer

    McGeever Family Office

    Ken Nelson
    Ken Nelson

    Angel Investor & Partner

    MedTech Advantage Fund

    Henk Westendorp
    Henk Westendorp

    Venture Partner, Lead Surgery, Head of Clinical Expertise

    NLC Health Ventures

    Tal Wenderow
    Tal Wenderow

    Managing Partner

    Star51 Capital

  • Jake Goble
    Jake Goble

    Innovation Leader, Medical Products Division

    W.L. Gore & Associates

    Amanda Gast
    Amanda Gast

    Global Business Leader

    W.L. Gore & Associates

    Teri Sirset
    Teri Sirset

    CEO

    DASI Simulations

    John Von Benecke
    John Von Benecke

    CEO

    Locate Bio

    Ryan Belaney
    Ryan Belaney

    President & CEO

    Phoenix Kinetics

    Teresa Prego
    Teresa Prego

    CEO

    EpiWatch

  • Doug Teany
    Doug Teany

    CEO

    Method AI

    Thomas Nichols
    Thomas Nichols

    CEO

    Pretika MedTech

    Bob Benkowski
    Bob Benkowski

    CEO

    Opsin Biotherapeutics

    Jim Buck
    Jim Buck

    President, CEO & Director

    Medcura

    Eldon Tate
    Eldon Tate

    CEO & Co-founder

    Inhibit Coatings

    Pablo Fernández Echeverría
    Pablo Fernández Echeverría

    CEO

    Polimerbio

  • Clement Vidal
    Clement Vidal

    President

    eCential Robotics

    Ruben Flores Saaib, Ph.D.
    Ruben Flores Saaib, Ph.D.

    CEO

    Regain BioMedicals

    Alex Herzlinger
    Alex Herzlinger

    Chief Business Officer (CBO)

    Highland Instruments

    Thomas Weindl
    Thomas Weindl

    CEO & Co-Founder

    OLI

    Coenraad Tamse
    Coenraad Tamse

    Chief Commercial Officer

    TrianecT

    Joey Mason
    Joey Mason

    Venture Partner

    Claret Capital Partners

  • David Neustaedter
    David Neustaedter

    Founder & CTO

    Deerfield Management

    Karthik Bolisetty
    Karthik Bolisetty

    Investment Manager

    Gilde Healthcare

    Caaj Greebe
    Caaj Greebe

    Partner

    Innovation Industries

    Justin Reed
    Justin Reed

    Managing Director

    Leerink Partners

    Ali Samiian
    Ali Samiian

    Founder and Managing Principal

    Poplar Access Advisors

    Auriel August
    Auriel August

    Principal

    Santé Ventures

  • Ashley Seehusen
    Ashley Seehusen

    Venture Partner

    Sante Ventures

    Tom Younker
    Tom Younker

    Senior Vice President, Global Marketing

    Argon Medical Devices

    Paul Ziegler
    Paul Ziegler

    President & CEO

    Augmedics

    Brad Sutton
    Brad Sutton

    Chief Medical Officer

    Boston Scientific

    Mike Nagel
    Mike Nagel

    CEO

    Raydiant Oximetry

    James Heinz
    James Heinz

    Chief Executive Officer

    Amsel Medical

  • Noam Josephy
    Noam Josephy

    CEO

    AQUAPASS

    Tammy Crawford
    Tammy Crawford

    CEO

    Aces Diagnostics

    Holly Ahern
    Holly Ahern

    Chief Scientific Officer

    Aces Diagnostics

    Lishan Aklog
    Lishan Aklog

    Executive Chairman

    Veris Health

    Joanna Nathan
    Joanna Nathan

    CEO & Co-Founder

    Prana Surgical

    Paul Spencer
    Paul Spencer

    President, Biomedical Division

    dsm-firmenich

  • Karim Karti
    Karim Karti

    CEO

    RapidAI

    Susana Amorim Lopes
    Susana Amorim Lopes

    Investment Manager

    Gilde Healthcare

    Daniel Teo
    Daniel Teo

    Managing Partner

    Hunniwell Lake Ventures

    Harm De Vries
    Harm De Vries

    General Partner

    Innovation Industries

    Gavin Leonard
    Gavin Leonard

    Chief Executive Officer

    MedTech Syndicates

    Talia Kirschbaum
    Talia Kirschbaum

    Investor

    MVM Partners

  • Erin Finefield
    Erin Finefield

    Principal

    New Day Venture Capital

    Paul Petherbridge
    Paul Petherbridge

    CEO

    LifeHealthcare

    Meir Dahan
    Meir Dahan

    Senior Vice President, Research & Development

    Argon Medical Devices

    Chris Kocheran
    Chris Kocheran

    Commercial Sales Director, Health Markets

    Battelle

    Andre Xiao
    Andre Xiao

    Chief Strategy Officer

    Pulnovo Medical

    Keith Carlton
    Keith Carlton

    Executive Chairman

    Newronika

  • Bradley Hubbard
    Bradley Hubbard

    CMO

    Bioheart

    Glenn Stiegman
    Glenn Stiegman

    Senior Vice President, Clinical, Regulatory and Quality

    MCRA

    John McDermott
    John McDermott

    Vice President, Reimbursement Strategy

    MCRA

    Kelley Kennedy
    Kelley Kennedy

    Vice President, MedTech

    IQVIA MedTech

    Alyssa Howard
    Alyssa Howard

    Vice President, Business Development

    MCRA

    Mike Blue
    Mike Blue

    President and CEO

    HistoSonics

  • Robert Hamilton
    Robert Hamilton

    CEO

    NeuraSignal

    John Brumfield
    John Brumfield

    CEO

    Berlin Heals

    Vincent Keereman
    Vincent Keereman

    CEO

    XEOS

    Mike Dolphin
    Mike Dolphin

    Chief Executive Officer

    GuideStar Medical Devices

    David Carey
    David Carey

    Chief Executive Officer

    Preceptis Medical

    Greg Walters
    Greg Walters

    CEO/President/Founder

    Excision Medical

  • Ryan Shelton
    Ryan Shelton

    CEO & Co-founder

    PhotoniCare

    Amir Danino
    Amir Danino

    Founder and CEO

    Innoventric

    James Alecxih
    James Alecxih

    CEO

    Virtual Incision

    Mohamed Abou-Alam
    Mohamed Abou-Alam

    CEO

    Precision Cardiovascular

    Chris Springate
    Chris Springate

    CEO

    ARC Medical

    Christian Pean
    Christian Pean

    Co-Founder, CEO

    RevelAi Health

  • Jim Surek
    Jim Surek

    CEO

    Valencia Technologies Corporation

    Dipu Ghosh
    Dipu Ghosh

    CEO

    Hepatiq

    Lakshmi Dasi
    Lakshmi Dasi

    Founder, CTO

    YoungHeartValve

    Dr. Philip Weissbrod
    Dr. Philip Weissbrod

    CEO and Co-Founder

    Channel Robotics

    George Kramer
    George Kramer

    Founder and CEO

    NeoCor

    William Altman
    William Altman

    CEO

    CorInnova

  • Lloyd Mencinger
    Lloyd Mencinger

    President & CEO

    Aqua Medical

    Danguole Altman
    Danguole Altman

    CEO

    Cx Precision Medicine

    Allen Meacham
    Allen Meacham

    President & CEO

    Stimdia Medical

    Robert Isaacs
    Robert Isaacs

    CEO

    TrackX Technology

    Brian McVerry
    Brian McVerry

    CTO

    Silq Technologies

    Tyler Zanon
    Tyler Zanon

    CEO, Co-Founder

    EndoShunt Medical

  • Gil Hakim
    Gil Hakim

    CEO

    Matricelf

    Shmuel Ben-Ezra
    Shmuel Ben-Ezra

    Co-founder and CEO

    NINA Medical

    David Newell
    David Newell

    Founder

    Seattle Neurosound Solutions

    Eric Sandberg
    Eric Sandberg

    Chief Business Officer

    Inomagen Therapeutics

    Neal Piper
    Neal Piper

    Founder & CEO

    Luminoah

    Ida Garakani Good
    Ida Garakani Good

    Chief Operations Officer

    Cerevia Neurosciences

  • Aaron Smith
    Aaron Smith

    Former Chief Executive Officer

    Artelon

    Rob Brown
    Rob Brown

    Commercial Strategy

    KLISBio

    Lauren Brenneman
    Lauren Brenneman

    Director, Business Development

    Simbex

    Heidi Herrick
    Heidi Herrick

    Executive Talent Director

    FloodGate Medical

    Joe McClung
    Joe McClung

    President

    FloodGate Medical

    Ashkon Rasooli
    Ashkon Rasooli

    Founder & CEO

    EnGenius Solutions

  • Yvonne Ma
    Yvonne Ma

    CEO

    Salt Medical

    Johnathon Bis
    Johnathon Bis

    Commercial Operations Director, Americas

    BSI

    Yeshwanth Pulijala
    Yeshwanth Pulijala

    CEO

    Scalpel AI

    Harald Steltzer
    Harald Steltzer

    CEO

    OrisDX

    Pall Johannesson
    Pall Johannesson

    Executive Vice President, Europe

    Greenlight Guru

    Matt Angle
    Matt Angle

    CEO & Founder

    Paradromics

  • Céline Puleo
    Céline Puleo

    Global Marketing Event Manager

    NAMSA

    Deven Hennon
    Deven Hennon

    Marketing Manager

    RQM+

    Ana Maiques
    Ana Maiques

    CEO & CoFounder

    Neuroelectrics

    Richard Dobberstein
    Richard Dobberstein

    Laboratory Manager

    Applus+ Keystone

    Lana Caron
    Lana Caron

    Chief Business Development Officer

    Vektor Medical

    Ryan Roberts
    Ryan Roberts

    Chief Commercial Officer

    Veranex

  • Ruth Segall
    Ruth Segall

    Associate

    Windham Capital Partners

    Bill Hunter
    Bill Hunter

    CEO

    Canary Medical.Inc.

    Bret Snyder
    Bret Snyder

    Chair and CEO

    W. L. Gore & Associates, Inc.

    Vish Kulkarni
    Vish Kulkarni

    Dir. of Product, Digital Health Emerging Tech

    Samsung

    George Davis
    George Davis

    Founder

    StrategicFeds

    Joseph Ferrara
    Joseph Ferrara

    Chief Strategy Officer

    Veranex

  • Meghan Boudreau
    Meghan Boudreau

    Marketing Director

    PwC

    Kara Egan
    Kara Egan

    CEO

    Teal Health

    Eric Dy
    Eric Dy

    Founder & CEO

    Bloomlife

    Hannes Holste
    Hannes Holste

    Director, Life Science Investments & Data Science

    Thiel Capital

    Timothy Still
    Timothy Still

    Operating Partner

    Revival Healthcare Capital

    John White
    John White

    Managing Director

    KCK Medtech

  • Lisa Suennen
    Lisa Suennen

    Managing Partner, American Heart Association Ventures

    American Heart Association

    Todd Usen
    Todd Usen

    President & CEO

    Adagio Medial

    Murielle Thinard McLane
    Murielle Thinard McLane

    President and Managing Partner

    Intuitive Ventures

    Terri Burke
    Terri Burke

    Senior Partner

    Intuitive Ventures

    Adam Hill
    Adam Hill

    CEO

    Acoustiic

    Roger Assaker
    Roger Assaker

    CEO

    MDSIM

  • Adom Dumanian
    Adom Dumanian

    COO

    MSi

    Owen Willis
    Owen Willis

    Founder and General Partner

    Opal Ventures

    Max Marchione
    Max Marchione

    Co-Founder

    Superpower

    Kelly Huang
    Kelly Huang

    CEO

    Elucid

    Dror Zerem
    Dror Zerem

    CEO

    FIZE Medical

    Dinesh Kumar
    Dinesh Kumar

    CEO

    Blend

  • Raymond W. Cohen
    Raymond W. Cohen

    Venture Partner

    Andera Partners and Sherpa HC Partners

    Ramin Mousavi
    Ramin Mousavi

    President & Chief Executive Officer

    CathWorks

    Eric Goslau
    Eric Goslau

    President & CEO | Co-Founder

    Transverse

    Susan Posner
    Susan Posner

    Partner, Leader of the MedTech Practice

    Health Advances

    Marc Jacob
    Marc Jacob

    Manager, Mergers & Acquisitions

    Karl Storz

    Howard Fullman
    Howard Fullman

    Senior Advisor

    Atoms VC

  • Stanton Rowe
    Stanton Rowe

    CEO

    Nidus Biomedical

    Jordi Martorell
    Jordi Martorell

    CEO & Co-Founder

    Aortyx

    Carolina Aguilar
    Carolina Aguilar

    CEO & Co-Founder

    INBRAIN Neuroelectronics

    Katerina Fialkovskaya
    Katerina Fialkovskaya

    Investment Director

    Philips

    Randy Preston
    Randy Preston

    Chief Business Officer

    Centese

    Conrad Rasmus
    Conrad Rasmus

    Co-CEO & Co-Founder

    Protembis

  • Axel Strombergsson
    Axel Strombergsson

    Vice President, QuickVault

    Veeva

    Maggie Nixon
    Maggie Nixon

    CEO

    Capstan Medical

    Stacey Pugh
    Stacey Pugh

    CEO

    Endogenex

    David Hochman
    David Hochman

    Chairman of the Board of Directors, CEO and Founder

    Orchestra BioMed

    Bryant Grigsby
    Bryant Grigsby

    CEO

    PDV MedTech

    Clay Nolan
    Clay Nolan

    Founder, CEO

    CoLabs

  • Will Kelly
    Will Kelly

    Associate

    Research Corporation Technologies

    Jon Norris
    Jon Norris

    Managing Director

    HSBC Innovation

    Lisa Carmel
    Lisa Carmel

    Chair, Business Development

    Mayo Clinic

    Kristina Meyer
    Kristina Meyer

    Director of Market Development

    AcuityMD

    Kate Garrett
    Kate Garrett

    Managing Partner

    Sonder Capital

    Nir Goldenberg
    Nir Goldenberg

    Director, Technology Development

    Mayo Clinic

  • Darren Sherman
    Darren Sherman

    President, Chief Operating Officer, Founder and member of Board of Directors

    Orchestra BioMed

    Bill Little
    Bill Little

    Executive Vice President, Corporate Development and Strategy

    Orchestra BioMed

    Omid Akhavan
    Omid Akhavan

    Managing Director

    Anthro Ventures

    Chris Bolten
    Chris Bolten

    MedTech IP Attorney

    Greenberg Traurig

    Robert Ward
    Robert Ward

    IP and Tech Shareholder

    Greenberg Traurig

    Swaril Mathur
    Swaril Mathur

    Vice President of Strategy & Growth

    MicroTransponder

  • Peter Noseworthy, MD
    Peter Noseworthy, MD

    Chair, Cardiac Electrophysiology, Professor, Medical Director, Department of Business Development

    Mayo Clinic

    Joshua Phillips
    Joshua Phillips

    Managing Partner

    Catalyst Health Ventures

    Valentina Agostoni
    Valentina Agostoni

    Principal

    TVM Capital

    Ryan Kaeding
    Ryan Kaeding

    Managing Director, Life Sciences & Healthcare

    Trinity Capital

    Azin Parhizgar
    Azin Parhizgar

    Managing Director

    415 Capital

    Luke Rohlen
    Luke Rohlen

    Vice President

    Ajax Health

  • Jason Rostovsky
    Jason Rostovsky

    Private Investments

    Viking Global Investors

    Carissa Black
    Carissa Black

    Director, Venture Capital

    Medtronic

    Yatharth Gupta
    Yatharth Gupta

    Strategy and Growth

    KARL STORZ

    Martha MClees
    Martha MClees

    Senior Corporate Relations Director

    Mayo Clinic

    Dan Sheehan
    Dan Sheehan

    Vice President, Venture Capital

    Medtronic

    Alix Sipahi
    Alix Sipahi

    Manager, Venture Capital

    Medtronic

  • Shai Ran Sapir
    Shai Ran Sapir

    Cardiovascular Portfolio Manager

    Mayo Clinic

    Omari Bouknight
    Omari Bouknight

    CEO

    Resonant Link Medical

    Lawrence Obstfeld
    Lawrence Obstfeld

    CEO

    Image Navigation

    Martin Herman
    Martin Herman

    CEO

    Powerful Medical

    Bankim Mehta
    Bankim Mehta

    CEO

    Lean Medical Technologies

    Muhammad Al-Qaisi
    Muhammad Al-Qaisi

    Founder & CEO

    Aliph Medical

  • David Doster
    David Doster

    CEO

    Rheoxtech

    Anthony Arnold
    Anthony Arnold

    CEO

    Sensydia

    Alexander Newton
    Alexander Newton

    CEO & Co-Founder

    Navi Medical Technologies

    David Jansen
    David Jansen

    President & CEO

    SAIL Fusion

    Olivier Visa
    Olivier Visa

    President and CEO

    Evergen

    Brett Wall
    Brett Wall

    EVP and President, Neurosciences Portfolio, Executive Sponsor African Descent Network

    Medtronic

  • Juliet Wegener
    Juliet Wegener

    Head of Strategy - US

    KARL STORZ

    Amir Rahimi
    Amir Rahimi

    Board Member, Technical

    Chemva

    Pratap Khanwilkar
    Pratap Khanwilkar

    Founder/CEO

    Miniscule

    Greg Parranto
    Greg Parranto

    CEO

    Endeavor Orthopaedics

    Hillary Pierce
    Hillary Pierce

    CEO and Co-Founder

    Total Flow Medical

    John Ralston
    John Ralston

    CEO, co-founder

    Neursantys

  • Kazu Okuda
    Kazu Okuda

    CEO

    Universal Brain

    Rick Thomson
    Rick Thomson

    President & CEO

    Sandia Medical Technologies

    Yoann Bonnamour
    Yoann Bonnamour

    Director - Venture Capital

    Mérieux Equity Partners

    David Bottomley
    David Bottomley

    Partner

    Bioshore Ventures

    Paul D'Agrosa
    Paul D'Agrosa

    Managing Director of Life Sciences

    Trinity Capital

    Tanja Dowe
    Tanja Dowe

    Managing Director

    Angelini Ventures

  • Sarah Fox
    Sarah Fox

    Senior Associate

    Angelini Ventures

    Cale Garverick
    Cale Garverick

    Director

    TD Securities

    Chris Kaster
    Chris Kaster

    Founder & Managing Partner

    Cadence Healthcare ventures

    Catherine Kiani
    Catherine Kiani

    Investor

    Elderberry Ventures

    Jeff Peters
    Jeff Peters

    Venture Partner

    OrbiMed

    Jeffrey Reid
    Jeffrey Reid

    General Partner

    Bioshore Ventures

  • Paul Russo
    Paul Russo

    Chairman & CEO

    K2X

    Vanessa Chang
    Vanessa Chang

    Associate Director, Business Development - M&A

    BD

    Nir Herlinger
    Nir Herlinger

    Senior Director, Strategy & Business Development (M&A)

    BD

    Takumi Uehara
    Takumi Uehara

    VP of Business Development, Digital Transformation

    Terumo

    Adam Wollowick
    Adam Wollowick

    Senior Business Development Director

    Stryker

    Luke Diehl
    Luke Diehl

    CEO

    Spark Spine

  • Ryan Neely
    Ryan Neely

    CEO/Co-Founder

    Skribe Medical

    Veronique Ameye
    Veronique Ameye

    CEO

    ElectraDx

    Joe Kiani
    Joe Kiani

    Founder & Executive Chairman

    Willow Laboratories

    Saumik Biswas
    Saumik Biswas

    CEO, President, and co-founder

    Tenomix

    Justin Sutherland
    Justin Sutherland

    CEO

    Realize Medical

    Anders Sideris
    Anders Sideris

    CEO & Co-Founder

    Somnair

  • Sofia Quinones-Vilela
    Sofia Quinones-Vilela

    Investment Analyst

    Orlando Health Ventures

    Jenny Barba
    Jenny Barba

    Founder, Managing Partner

    Features Capital

    Alexander Schmitz
    Alexander Schmitz

    Partner

    Endeavour Vision

    Omar Khateeb
    Omar Khateeb

    Founder - Medtech Growth & Marketing Agency

    MarketCraft

    Konrad Dobschuetz
    Konrad Dobschuetz

    Founder Director

    Lead Advisory & Intelligence

    Alexandru Plesoianu
    Alexandru Plesoianu

    CEO

    CARDIOVASCULAR ENGINEERING

  • Karun Naga
    Karun Naga

    Partner

    The Foundry

    Adam Clark
    Adam Clark

    CEO

    IMRA Surgical

    Ajay Wakhloo
    Ajay Wakhloo

    CEO and President

    Prometheus Therapeutics & Neurofine

    Ori Braun
    Ori Braun

    CEO

    ART MEDICAL

    James Huie
    James Huie

    Partner - Corporate

    Paul Hastings

    Isaiah Reeves
    Isaiah Reeves

    Analyst

    Solas BioVentures

  • Hanson Gifford
    Hanson Gifford

    Managing Partner

    Bloom Therapeutics AKA FoundryGLP

    Daniel Hawkins
    Daniel Hawkins

    Founder

    Vista.ai

    Prashant Chopra
    Prashant Chopra

    Founding CEO

    Petal Surgical, Inc.

    Breanne Everett
    Breanne Everett

    CEO and President

    Orpyx

    Jayon Wang
    Jayon Wang

    Partner

    MicroPort Scientific

    Rebecca Raabe
    Rebecca Raabe

    Investment Partner

    SPRIG Equity

  • Fernando Pacheco
    Fernando Pacheco

    Partner

    Endeavour Vision

    Brandon Noll
    Brandon Noll

    Director, Medtech and Lifetech

    Plug and Play Indiana

    Fred Moll
    Fred Moll

    Co-Chair & Partner

    Sonder Capital

    Luc Marengere
    Luc Marengere

    Managing Partner

    TVM Capital

    Tim Lew
    Tim Lew

    Managing Director, Life Science and Healthcare Venture Banking

    Stifel Bank

    Kim High
    Kim High

    Venture Partner & OrthoSpine Lead

    NLC Health Ventures

  • Ariana Dacruz
    Ariana Dacruz

    Senior Vice President, Life Science and Healthcare Venture Banking

    Stifel Bank

    Harris Kaplan
    Harris Kaplan

    Managing Partner

    Litmys

    Bill Schulz
    Bill Schulz

    Principal, Corporate Strategy & Development

    Hologic

    Amanda LoGuidice
    Amanda LoGuidice

    Chief Scientific Officer

    Evergen

    Fumiko Jenkins
    Fumiko Jenkins

    Sr. Manager, Business Development & Integration

    MicroVention-Terumo

    Holly Scott
    Holly Scott

    Vice President & Partner

    The Mullings Group

  • Sydney Robinson
    Sydney Robinson

    CEO & Co-Founder

    Vessl Prosthetics

    Gunther Schrappe
    Gunther Schrappe

    CEO

    3PH Alliance

    Nitzan Hirsh
    Nitzan Hirsh

    Co-Founder and CEO

    LuSeed Vascular

    Marie-Louise Little
    Marie-Louise Little

    CEO

    O2matic

    Amaan Mazhar
    Amaan Mazhar

    Chief Executive Officer

    Modulim

    Cecilia Muldoon
    Cecilia Muldoon

    Founder & CEO

    Serox

  • Emily Mirro
    Emily Mirro

    President and Co-Founder

    SynchNeuro

    Liesl Nel-Themaat
    Liesl Nel-Themaat

    Advisor

    Noor Sciences

    Nirdesh Gupta
    Nirdesh Gupta

    Managing Partner

    Cedars-Sinai Medical Center

    Kaveh Azartash
    Kaveh Azartash

    CEO

    Noor Sciences

    Ivanny Franklin
    Ivanny Franklin

    Managing Partner

    MedSight Capital

    Kevin Eisenfrats
    Kevin Eisenfrats

    Co-Founder and CEO

    Contraline

  • Arik Ben Ishay
    Arik Ben Ishay

    Co-Founder and CEO

    Biobeat

    Suzie Bangle
    Suzie Bangle

    Head of Medical Device

    Barrington James

    Arjun Bansal
    Arjun Bansal

    CEO & Co-founder

    Everest by Log10

    Thijs Smit
    Thijs Smit

    Co-Founder and CEO

    OptimalPSI

    Alexis Peyroles
    Alexis Peyroles

    CEO

    BetaGlue Therapeutics SpA

    Joshua Fischer
    Joshua Fischer

    COO

    LIQID Medical

  • Derek Sham
    Derek Sham

    Founder & Chief Executive Officer

    Cosm Medical

    Subhasis Banerji
    Subhasis Banerji

    Founder Inventor, Managing Director

    Synphne

    Max Perelman
    Max Perelman

    Co-Founder, President & CEO

    Biomeme

    Harry Blumsack
    Harry Blumsack

    Founder & CEO

    Infera

    Frank Rahmani
    Frank Rahmani

    Partner

    Sidley Austin LLP

    Jason Frye
    Jason Frye

    Founder

    Terrapin

  • Melissa Lederer
    Melissa Lederer

    Chief Experience Officer

    MHUB Ventures

    Tai Hah
    Tai Hah

    Managing Director

    Citigroup, Inc.

    Yuval Mandelbaum
    Yuval Mandelbaum

    CEO

    Discure Technologies

    Ofer Shalev
    Ofer Shalev

    CEO & Founder

    New Phase

    Nick Diamond
    Nick Diamond

    Shareholder

    Greenberg Traurig

    Amy Lorincz
    Amy Lorincz

    CEO & Co-Founder

    vopemed

  • Christina Goudy
    Christina Goudy

    CEO and co-founder

    Reach Orthopaedics

    David Crabb
    David Crabb

    Founder and CEO

    Rovex

    Ryan Myers
    Ryan Myers

    CEO & Co-Founder

    CranioSense

    Jim Fidacaro
    Jim Fidacaro

    CEO

    Sonion Health

    Svetla Kibota
    Svetla Kibota

    Founder

    Bloom Health Creative

    Cambre Kelly
    Cambre Kelly

    CEO and Co-founder

    Reselute

  • Stephen From
    Stephen From

    CEO

    Vicarious Surgical

    Yashar Vahedein
    Yashar Vahedein

    Co-Founder & CEO

    Coredio

    Krishna Agarwal
    Krishna Agarwal

    CEO & Founder

    Spermotile

    Joseph McGinley
    Joseph McGinley

    Founder & CEO

    McGinley Orthoperids

    Kristy Kennedy
    Kristy Kennedy

    Director, Business Development

    Blue Goat Cyber

    Joseph Ischia
    Joseph Ischia

    CEO and Co-Founder

    Akeeko Medical

  • Sheldon Goldstein
    Sheldon Goldstein

    CEO

    Coagulation Sciences

    Amaury Ciurana
    Amaury Ciurana

    CEO & Co-Founder

    REEV

    Matthew Schemmel
    Matthew Schemmel

    Vice President

    Silicon Valley Bank

    Edward Ruppel
    Edward Ruppel

    Senior Associate

    Nexus Neurotech Ventures

    Neil Parikh
    Neil Parikh

    Principal

    HealthQuest Capital

    Chris Moniz
    Chris Moniz

    Managing Director

    HSBC

  • Jon Lundt
    Jon Lundt

    Principal

    Nexus NeuroTech Ventures

    Matt Gilbert
    Matt Gilbert

    Managing Director

    XMS Capital Partners

    Anthony Fortier
    Anthony Fortier

    Vice President, Life Science and Healthcare Technology

    Silicon Valley Bank

    Stefan Fischer
    Stefan Fischer

    Managing Partner

    TVM Capital Life Science

    Matt Donne
    Matt Donne

    Managing Director - Life Science & Healthcare VC Relations

    Silicon Valley Bank

    Daniel Di Piazza
    Daniel Di Piazza

    Managing Director

    JLL Partners

  • Josh DeFonzo
    Josh DeFonzo

    Co-Founder and CEO

    Mendaera, Inc.

    Michel Habib
    Michel Habib

    Co-Founder & Managing General Partner

    ALIVE Israel HealthTech Fund

    Joe Kiani
    Joe Kiani

    CEO & President

    Willow Labs

    Nicole Ager
    Nicole Ager

    Chief Marketing Officer

    The Mullings Group

    Murthy Simhambhatla
    Murthy Simhambhatla

    President/CEO

    SetPoint Medical

    Heather Roxborough
    Heather Roxborough

    Senior Partner

    Oxford Science Enterprises

  • Adam Rosenwach
    Adam Rosenwach

    Partner and Chief Business Officer

    Coridea

    Chris Cleary
    Chris Cleary

    CEO

    Biomergence Capital LLC

    Sean Salmon
    Sean Salmon

    EVP & President, Cardiovascular

    Zamboni Holdings LLC

    Kregg Koch
    Kregg Koch

    US Patent Attorney

    Knobbe Martens

    Patrick O’Donnell
    Patrick O’Donnell

    President & CEO

    NanoHive Medical LLC

previous next
LSI USA ‘26
See Who’s Presenting
at LSI USA ‘26
We meticulously select founders and operators
building the next generation of breakthrough
medtech and healthtech companies.
Apply to Present at LSI USA ‘26 View Selected Startups

  • 4D Medicine Ltd is a UK-based company developing next-generation implantable devices using 4Degra®, a proprietary resorbable biomaterial based on polycarbonate urethane chemistry. Designed for use in both soft and load-bearing applications, 4Degra® overcomes key performance limitations of legacy materials like PLA and PLGA. The company’s first product, a range of interference screws for soft tissue–bone fixation, is expected to launch in the U.S. in 2026. By enabling advanced processing techniques such as 3D printing and offering tunable mechanical properties, 4D Medicine aims to transform the design and performance of resorbable medical implants. Visit website.

    arrow
    Phil Smith

    CEO

  • Aclarion is a SaaS company leveraging MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful spinal discs. Its cloud-based platform processes raw spectral data collected during a standard MRI, transforming it into clear metabolic biomarkers through proprietary signal processing and augmented intelligence. The resulting disc-specific metrics support more informed clinical decision-making for patients with chronic low back pain. Visit website.

    arrow
    Brent Ness

    CEO

  • Acuamark Diagnostics is optimizing qPCR and dPCR for early cancer detection and cancer recurrence. Its approach is designed to provide highly accurate results to physicians and patients at a fraction of the cost per life saved. With market leading clinical results in stage 1-4 colorectal cancer, Acuamark is currently developing diagnostics for multiple cancers. US launch of its first products is estimated in 2026.  Visit website.

    arrow
    Bernard Peperstraete

    Cofounder & CEO

  • AdjuCor is developing reBEAT – an extravascular heart assist device for patients with advanced heart failure. reBEAT is a novel, minimally invasive, epicardial, biventricular mechanical circulatory support system designed to assist one or both ventricles without contacting the blood. Visit website.

    arrow
    Stephen Wildhirt

    CEO

  • The SteriPlas Cold Plasma medical device by Adtec Healthcare Ltd (Twickenham, London UK) is a strong antibacterial with proven clinical efficacy for the management of chronic wounds, surgical site infections, and diabetic foot ulcers typically complicated with antimicrobial resistance (AMR) and biofilm. Where conventional therapies, such as antibiotics, fail to destroy superbugs protected within biofilm leading to a worsening infection, the SteriPlas delivers a quick, painless and fast-acting solution with faster treatment times than standard of care and reduced hospital stays.  Visit website.

    arrow
    Mary McGovern

    CEO

  • Ajemiri Neurotech is developing a portable, dry-sensor EEG platform combined with machine learning to detect electrophysiological biomarkers of Alzheimer’s disease. Our approach enables low-cost, non-invasive brain health screening suitable for memory clinics, primary care, and clinical trial recruitment.

    arrow
    Joshua Ajemiri

    Founder & CEO

  • Altoida is developing the NeuroMarker Platform to transform how cognitive disorders are detected, monitored, and managed. The platform enables continuous, real-time monitoring of cognitive function, allowing for early identification of subtle changes. By providing actionable insights, it supports clinicians in personalizing treatment plans and tracking patient progress over time. Altoida’s approach also enhances patient engagement by offering clear visibility into cognitive health, empowering individuals to actively participate in their care. Visit website.

    arrow
    Marc Jones

    CEO

  • Amber Implants is developing the VCFix Spinal System, a vertebral body augmentation system to improve pain control and stabilize the spine in patients suffering from vertebral compression fractures (VCFs). The company intends to improve the treatment of painful spinal fractures through improvements in mechanical performance, providing controlled restoration via more patient-specific implant customization, and offering superior stabilization that reduces the biomechanical load on the vertebral body and the spine. Visit website.

    arrow
    Mohammad Ahmadi

    Co-founder & CTO

  • Amplifi Vascular is developing the Amplifi™ Vein Dilation System, a proprietary blood pump technology designed to enlarge veins and improve outcomes for patients requiring arteriovenous fistula (AVF) surgery. The system is intended to increase AVF eligibility, accelerate maturation, reduce failure rates, and extend primary patency. By addressing key challenges in dialysis access, Amplifi aims to improve treatment outcomes for patients with end-stage renal disease. Visit website.

    arrow
    Sean Morris

    President & CEO

  • Anaut is a Tokyo-based technology company developing AI precision mapping technology to enhance surgical outcomes and reduce complications. Its flagship product, Surgical Vision EUREKA, uses advanced algorithms and deep learning to provide real-time mapping of the surgical field. The technology aims to support surgeons in navigating complex anatomy with greater accuracy. Visit website.

    arrow
    Roy Bartel-Taverner, MD

    Chief Medical Officer (Interim)

  • AngioInsight is developing AngioAI+, an AI-driven solution for real-time, non-invasive assessment of stenosis and Fractional Flow Reserve (FFR). The technology provides rapid and accurate data on flow dynamics and anatomy, aiding in the detection of microvascular disease. By integrating automated AI diagnostics into the workflow, AngioAI+ enhances precision and efficiency in cardiovascular assessment. Visit website.

    arrow
    Scott Burger

    CEO

  • Treating gastrointestinal disease with disruptive, vapor-based endoscopic ablation therapy. Visit website.

    arrow
    Lloyd Mencinger

    President & CEO

  • Arsenal Medical develops innovative biomaterials to solve challenging and underserved medical problems. Our lead products target neurovascular and trauma conditions providing control of blood flow to tumors and bleeding conditions, such as hemorrhage.  Visit website.

    arrow
    Upma Sharma

    President & CEO

  • ART MEDICAL develops the smART+ Platform to address malnutrition and reduce the risk of ventilator-associated pneumonia in intensive care units. The platform offers features that enhance staff productivity and enable precise, data-driven care. Clinically proven to reduce ICU stays and ventilation duration by 3.3 days, smART+ achieves up to 100% feeding efficiency through real-time reflux detection, dynamic nutritional compensation, and continuous tube positioning monitoring. Visit website.

    arrow
    Ori Braun

    CEO

  • AthenaDiax produces a portable ECG device and software currently in use within the Italian clinical market to diagnose patient heart health. Our product performs cardiac diagnostics that monitor and detect heart issues for early treatment of our patients. Our next stage is to enter the US market to provide proactive self-service heart monitoring directly to consumers. Visit website.

    arrow
    David Schwietz

    COO & CIO

  • Axena Health is dedicated to improving the lives of women with pelvic floor disorders. The company's Leva Pelvic Health system helps women train and strengthen their pelvic floor muscles from their homes to improve the management of stress, mixed, and mild-to-moderate urinary incontinence and chronic fecal incontinence.  Visit website.

    arrow
    Randy Pritchard

    CEO

  • Axorus develops a contact lens to restore sight for blind patients suffering from dry AMD (age-related macular degeneration) and Retinitis Pigmentosa, based on patented photoacoustic technology from Boston University. Visit website.

    arrow
    Jean-Damien Louise

    CEO

  • AyrFlo is advancing a new category of physiological monitoring called Breathonics, which captures the mechanics of airflow through the body’s natural airway system. Unlike traditional tools that rely on indirect proxies such as pulse oximetry or CO₂, AyrFlo’s technology measures directional airflow velocity continuously and non-invasively. This approach enables new clinical applications in areas such as post-surgical care and respiratory disease. AyrFlo aims to establish a new standard for monitoring respiratory function with real-time, source-based measurement. Visit website.

    arrow
    Guelay Bilen-Rosas

    CEO

  • Berlin Heals is developing the C-MIC system, an implantable electroceutical device that delivers a constant, but minimal, electrical direct current that mimics the physiological electrical currents produced by the heart. The device is a near-curative treatment for patients with heart failure that propagates the reverse remodeling of cardiac muscle tissue to restore heart function and size, thereby reducing the symptoms of heart failure and improving quality of life. Visit website.

    arrow
    John Brumfield

    CEO

  • Biobot Surgical's mission is to revolutionize urologic oncology care with the Mona Lisa platform, which enables robotic-assisted biopsy and treatment of prostate cancer  Visit website.

    arrow
    Adrian Whitford

    President

  • BIOCAPTIVA is a leading innovator in liquid biopsy technology, transforming diagnostic workflows through its proprietary msX™ platform. This breakthrough technology enables direct extraction of high-quality circulating cell-free DNA (cfDNA) and RNA from biological fluids, including whole blood without the need for chemical reagents. The msX platform addresses critical market needs for cost efficiency, scalability, and multi-omics compatibility, making it a cornerstone in advancing precision medicine. Visit website.

    arrow
    Jeremy Wheeler

    CEO

  • Novel medical devices to enhance the reliability and safety of orthopedics procedures.  Visit website.

    arrow
    Kambiz Behzadi

    President

  • Brain4care offers an FDA-cleared and non-invasive Intracranial Pressure (ICP) dynamics monitoring technology, eliminating the invasiveness of the current gold standard and unlocking its applicability for patients with brain damage, beyond the ICU. By breaking down the barriers to accessibility and expanding its utility by using an AI platform, the company aims to make ICP monitoring a routine and essential part of patient care anytime and anywhere. Visit website.

    arrow
    Carlos Bremer

    President North American Division

  • BrainSpace is developing a solution to simplify critical care in neurocritical patients. BrainSpace is committed to improving the way brain pressure is managed in patients recovering from stroke, traumatic brain injury, and neurosurgery. Currently patients requiring intracranial pressure management must be meticulously monitored and measured hourly by a nurse. The company has developed an automated monitoring solution as an alternative to the antiquated drainage monitoring relying on a manometer-based drain and blood pressure monitor that eliminates the hassle for patients and providers while improving the quality of data being captured for researchers and physicians. Visit website.

    arrow
    Caitlin Morse

    CEO

  • Byonyks is reinventing peritoneal dialysis so that patients can maintain a lifestyle where they can receive treatment at home, continue to earn a living, avoid the exhaustion of hemodialysis, protect their residual kidney function, and improve their heart health. 52% of dialysis patients die because of heart failure. Visit website.

    arrow
    Farrukh Usman

    Founder and CEO

  • CAIRA is developing software for advanced joint replacement. The software utilizes radar technology to improve navigation during manual and robotic surgery. The company's first product is a navigation system for use during knee replacement surgery. Visit website.

    arrow
    Jon Greenwald

    CEO

  • Calla Lily Clinical Care is a women's health focused company which has developed the proprietary Callavid® platform for intravaginal drug delivery. Initial target indications are in IVF and miscarriage prevention, followed by delivery of live biotherapeutics (LBPs) to reduce antibiotic usage which contributes to antimicrobial resistance (AMR). Further use-cases include effective sample collection to facilitate the next generation of biomarker-based diagnostic tests for endometriosis and a wide range of other conditions. Visit website.

    arrow
    Lara Zibners

    Co-Founder & Chairman

  • CAPS Medical (Israel) has developed a proprietary PlasmaSure technology that uses non thermal plasma to selectively target tumors through minimally invasive procedures. The PlasmaSure system uses existing minimally invasive tools and robotic systems, targeting a $100B TAM. CAPS effectively eliminates cancerous cells while preserving healthy tissue, allowing treatments to move from the operating room into a doctor's clinic. The technology is clinically tested and applicable to wide range of tumors. Visit website.

    arrow
    Ilan Uchitel

    CEO

  • This approach has been validated in a confirmatory/pivotal study, on patient suffering from symptomatic Severe Aortic Stenosis (sSAS), and not recommanded for immediate TAVR or SAVR ore refusing such interventions. As next steps, Cardiawave will support studies to demonstrate the value of Valvosoft on patients suffering from Moderate Aortic Stenosis. Visit website.

    arrow
    Carine Schorochoff

    CEO

  • CDX is a compact portable extracorporeal bypass pump for partial cardio-pulmonary support, adaptable to multiple circuit configurations including oxygenators. CDX's technology is an innovative, light-weight support system with multiple power options. The CDX pump platform is a disposable cartridge combined with a re-useable controller and stator. The entire system is less than 6 pounds in weight and can be primed and ready to support in less than 2 minutes. visit website

    arrow
    Gopal K. Chopra

    Co-CEO

  • Cellviva is a clinical-stage platform company developing novel Anti-VEGF therapies for ophthalmology and dermatology, targeting conditions that affect millions globally. Backed by a leadership team with deep industry expertise, Cellviva's approach is supported by strong IP protection, trade secrets, and a fast-track FDA approval pathway. Strategic partnerships in development and manufacturing help de-risk capital investment and accelerate time to revenue, projected by 2028. Visit website.

    arrow
    Rahul Chopra

    CEO

  • CergenX is developing an AI-powered solution to identify newborns at highest risk of brain injury. Its FDA-designated breakthrough device, CergenX Wave, delivers expert-informed brain function assessments at the point of care in just 15 minutes. The technology aims to support timely intervention and improve outcomes in neonatal neuroprotective care. Visit website.

    arrow
    Jason Mowles

    CEO

  • ChamberTech is a UK-based MedTech startup pioneering the first hybrid endocardial/epicardial pulsed field ablation (PFA) system for atrial fibrillation. Our catheter platform integrates novel electrode design, selective energy delivery, and dual-access ablation to achieve more durable lesions with enhanced safety. Supported by a £1.5M Innovate UK Biomedical Catalyst grant, ChamberTech is advancing toward early feasibility human studies following successful preclinical validation.

    arrow
    Richard Chambers

    Founder & CEO

  • Charco Neurotech has an innovative medical device that is improving quality of life for People with Parkinson’s disease, the world’s fastest growing neurological condition. CUE1+ is an easy to use non-invasive, wearable device that has been shown to deliver clinically meaningful improvement in the motor symptoms associated with Parkinson’s disease, restoring mobility and quality of life to the patient, with the potential to significantly reduce care costs. Visit website.

    arrow
    Andrew Mullen

    CEO

  • Circular Genomics is delivering precision medicine in neurology and mental health using novel, brain-enriched circular RNA (circRNA) biomarkers. We are delivering disruptive diagnostic, prognostic and therapy selection tools that radically transform the standard of care in diseases such as Alzheimer’s and depression, to elevate the standard of care,  transform lives rna restore hope. Visit website.

    arrow
    Paul Sargeant, PhD

    President and Chief Executive Officer, Member of Board of Directors

  • Clairity develops AI-driven tools to enhance breast cancer screening and risk assessment. Its platform utilizes deep learning models to analyze mammographic images, aiming to improve early detection, reduce racial and ethnic biases, and personalize care plans. The technology is grounded in decades of research led by Dr. Connie Lehman at institutions such as Mass General Brigham and MIT. Clairity's approach seeks to transform mammography from a one-size-fits-all model to a precision medicine framework. Visit website.

    arrow
    Jeff Luber

    CEO

  • Connected Consumables integrates connectivity into infusion consumables to create a cloud to vessel end-to-end digital solution. The system enables safer, faster and automated therapies with a superior patient experience. First clinical applications are targeted at both center-based and home oncological therapy. Visit website.

    arrow
    Nora Herzog

    CEO

  • Coramaze Technologies is developing an fast end effective solution for the treatment of tricuspid regurgitation. The TriPair system is deigned to be anchored atraumatically to the right atrium. The device is intended to be easily placed in a procedure taking less than twenty minutes, without the need for anesthesia or TEE. TriPair is agnostic of valve morphology and can be retrieved if necessary Visit website.

    arrow
    Jochen Reinöhl

    CEO

  • CorTec develops and manufactures implantable neurotechnology devices, components, and sub-assemblies for medical devices, clinical studies, and research applications. With over a decade of experience, the company supports partners from early concept through to commercialization. CorTec aims to be the development and manufacturing partner of choice for implantable technologies, enabling the next generation of medical innovation. Visit website.

    arrow
    Martin Schuettler

    CTO

  • Corticale develops next-generation brain-computer interface (BCI) technologies to treat motor and speech disorders linked to brain-related diseases. Its implant platform enables simultaneous interaction with thousands of neurons across broad brain regions, offering highly detailed signals to AI-based decoders. This level of neural communication aims to improve decoding performance, stability, and treatment efficacy beyond the limitations of current BCI systems. Visit website.

    arrow
    Fabio Boi

    CTO

  • CorWave develops and manufactures innovative implantable blood pumps based on a breakthrough membrane technology. Visit website.

    arrow
    Louis de Lillers

    CEO

  • Cresilon is a biotechnology company that develops, manufactures, and markets hemostatic medical devices utilizing the company’s proprietary hydrogel technology. The company’s plant-based technology has revolutionized the current standard by stopping bleeding in seconds. The company’s current and future product lines target trauma care, biosurgery, and animal health.  Visit website.

    arrow
    Joe Landolina

    CEO and Co-Founder

  • Crimson Scientific is building a modernized ECG with the goal of making cardiac diagnostics fast, accurate, and simple. Their device is a conformable and reusable weighted pad that simply lays on the patient’s chest without the need for adhesives or wires. The result is sent directly to an existing ECG machine for printing and archiving. Visit website.

    arrow
    Michael Cetta

    CEO

  • Crocevia Medical is developing a solution for unmet needs in the neurovascular space. Visit website.

    arrow
    Tamir Nahmias

    CEO

  • Cryosa has developed a novel, minimally invasive, obstructive sleep apnea (OSA) treatment that does not require a mask or an implant. Cryosa targets a root cause of OSA, excess fatty tissue. By “CoolsculptingTM” the tissue, it reduces volume and opens the airway to improve disease severity and symptoms. Cryosa was founded in 2018 and is located in Arden Hills, MN. Visit website.

    arrow
    Laura Stoltenberg

    President and CEO

  • CustomSurg solves complex bone fractures. The technology, originally developed at Harvard Medical School and ETH Zurich, allows surgeons to treat complex bone fractures based on a clinically validated algorithm, making surgeries simpler, better, and faster. The device has recently been awarded breakthrough designation by the FDA. Visit website.

    arrow
    Valentin Splett

    Co-CEO

  • Cypher Medical has developed a novel technology for visualizing red blood cell sedimentation. By integrating this technology into a waste container, it automatically separates red blood cells from other fluids, providing a fast and efficient method for identifying red blood cell sedimentation during surgery or childbirth. This patented solution can be applied to various biological fluid collection products. Cypher Medical is based in Texas and has partnered with an internationally recognized tech-development organization to advance its product development. Visit website.

    arrow
    Chris Carew

    CEO

  • DeepSight Technology develops advanced medical imaging solutions using proprietary sensing technology to enhance diagnostic ultrasound capabilities. The company’s NeedleVue Technology is designed to improve ultrasound-assisted needle guidance, addressing challenges such as complex calibration, reduced sensitivity, and angle dependence. By integrating innovative sensor technology with interventional devices, NeedleVue enables real-time verification of device placement, aiming to reduce procedural uncertainty and streamline interventional workflows. DeepSight Technology operates from the San Francisco Bay Area and Clayton, Missouri, with a focus on expanding the range and effectiveness of diagnostic ultrasound. Visit website.

    arrow
    Diku Mandavia

    Chief Medical Officer

  • Description coming soon. Visit website.

    arrow
    Steven Mickelsen

    CEO

  • Dialybrid develops hybrid vascular grafts based on proprietary Silkothane®, a novel composite material joining the biocompatibility of silk fibroin and the elasticity of polyurethane. The first product in the pipeline is SAG (Silkothane® Arteriovenous Graft), a semi-degradable arteriovenous graft for use as hemodialysis vascular access, offering the short-term usability of synthetic grafts and the long-term performances of native fistulae. The product is currently ready to be tested in a first-in-human study. Visit website.

    arrow
    Stefania Riboldi

    Project Coordinator

  • Dxcover’s proprietary PANAROMIC™ Platform shines light on the difficulty of early cancer diagnosis. By utilizing a multiomic spectral analysis (MOSA-Dx™) approach to detect cancer, the platform can detect the presence of disease with minute volumes of sample, with a turnaround time of one day. This technology goes beyond other liquid biopsy methods by harnessing the power of AI to capture the promise of the multiome, allowing early-stage detection of a range of solid tumors. Dxcover's unique AI algorithms are built on data; over 9000 patients and 250,000 spectra ensure robust diagnostic performance that can be tuned for high sensitivity or specificity. The test result is designed to be a valuable tool for clinicians to make rapid and appropriate patient management decisions. Dxcover’s proprietary technology is patented globally. Visit website.

    arrow
    Matthew Baker

    CEO

  • EBAMed develops innovative solutions for non-invasive and painless treatment of heart arrhythmias by using radiotherapy.  The company's technology consists of hardware and software components that enable non-invasive heart motion imaging that synchronizes in real-time with a therapeutic proton beam.  Visit website.

    arrow
    Marina Izzo

    CEO

  • Echopoint Medical is developing a family of optical-fiber based sensors which integrate into microcatheters to guide and improve outcomes during interventional cardiology procedures. The company's iKor platform translates ultrasonic signals to measure blood pressure and flow to more accurately assess, diagnose and treat patients with coronary artery disease and coronary microvascular dysfunction. Visit website.

    arrow
    Antony Odell

    CEO

  • EFA developed RevDx™, a revolutionary, CE-approved, mobile, and fully automated diagnostic system for the point of care, including primary care physicians, home-care, emergency, and remote locations. A very easy-to-use process from a finger prick to results in a few minutes. The first application is the Complete Blood Count test and more to follow Visit website.

    arrow
    Yoel Ezra

    CEO & Founder

  • ElectraDx has developed the first lab-accurate, ultra-low-cost community ad home based diagnostic platform using proprietary intelligent electronic strip technology. Our device delivers results from a simple fingerstick in under10 minutes, connects securely to healthcare systems, and supports a broad test menu covering over 70% of common lab tests. With an initial focus on cardiac markers, we are shifting diagnostics from hospitals into every home to enable earlier intervention and better health outcomes. Visit website.

    arrow
    Veronique Ameye

    CEO

  • Embolic debris is released into a patient’s bloodstream during any transcatheter heart procedure such as TAVR. This debris causes ischemic brain damage that is associated with stroke and cognitive decline, as well as damage to major organs such as kidneys. Emboline, Inc. is a privately held medical technology company based in Santa Cruz, CA that has developed the Emboliner® Embolic Protection Catheter, which is a capture-and-remove embolic filter providing full brain and body protection to reduce stroke, cognitive decline and kidney damage caused by embolic debris released in a patient’s bloodstream during such procedures. Visit website.

    arrow
    Scott Russell

    CEO

  • Enzyre is developing the ENZYSYSTEM, a near-patient blood coagulation testing platform that combines a painless sampling device, single-use microfluidic cartridges, and a cloud-connected processor to deliver rapid results for remote therapy management. Visit website.

    arrow
    Waander Van Heerde

    CSO

  • EP Solutions is improving clinical outcomes in cardiac resynchronization therapy cases through the use of noninvasive cardiac mapping technology. The company's Amycard 01C is an electrophysiology workstation that records body surface electrograms to create optimized 3D heart models that merge ECG data with anatomical data obtained from medical imaging. EP Solutions' technology helps physicians accurately place CRT leads during implantation and optimize devices during follow-up visits. Visit website.

    arrow
    Marcin Golebicki

    CEO

  • Epion Therapeutics is developing a minimally-invasive treatment that can bring early intervention to patients with corneal degeneration. Keratoconus is a common type of corneal ectasia that results in corneal thinning that progresses to the cornea taking on a conical shape that causes functional vision loss. Epion’s EpiSmart solution combines the delivery of a high concentration of riboflavin into the stroma with a UVA light device to optimize cross-linking and enhance therapeutic effectiveness.  Visit website.

    arrow
    Michael Webb

    President & CEO

  • Certalign is an industry changing, patented ‘one size fits all’ needle guide and stabilizer for ultrasound guided procedures (intravenous cannulation, nerve blocks, biopsies among others), the only device of its kind designed to accept ultrasound probes and needles of all sizes/types from most common manufacturers.   Certalign will transform this space enabling crucial treatment to be provided safely, effectively and in a timely manner, delivering better patient outcomes in a cost-effective way for healthcare providers.  

    arrow
    Preshan Jeevaratnam

    Chief Medical Officer

  • Flomics Biotech is developing a revolutionary liquid biopsy test that is capable of detecting multiple types of cancer with high accuracy and with the convenience of a standard blood extraction. By combining Genomics and Artificial Intelligence we detect molecular patterns associated with the disease that are capable of directing diagnosis even before the first symptoms appear. By detecting cancer in early stages, we make sure everybody gets the best odds to win the battle against this devastating disease. Visit website.

    arrow
    João Curado

    CEO

  • Fluid Biomed is developing the world’s first bioabsorbable neurovascular stent to cure brain aneurysms Visit website.

    arrow
    John Wong

    CEO

  • Galena Innovations is developing the solution to spontaneous preterm birth. Unlike traditional interventions that focus on compressing the cervix, the Hannah Cervical Cup™ employs a revolutionary stretching technique. This innovative approach increases cervical stiffness and remodels collagen, addressing spontaneous preterm birth in a unique and effective manner.  Visit website.

    arrow
    Ashley Crafton

    CEO & Founder

  • Inspired by the ankle joint, which is less prone to arthritis despite carrying more weight than the hip, MaltaHip features three unidirectional articulations made from clinically accepted materials that closely mimic real joint motion, offering greater range of motion and joint stability than existing hip replacement implants. Cadaveric surgeries by leading orthopaedic surgeons from Malta and the UK showed that MaltaHip delivers excellent stability and can accommodate extreme joint angles without dislocating. MaltaHip's design also addresses the problem of wear, with laboratory testing at EndoLab® in Germany simulating over five years of walking, confirming that MaltaHip wears at least 75% less than conventional implants, translating into the potential for the implant to last 50+ years; double that of current hip implants available on the market. Visit website.

    arrow
    Simon Mifsud

    CEO

  • GID BIO is a late-clinical-stage medical device company pioneering a point-of-care autologous cell therapy platform for treating chronic degenerative diseases, starting with knee osteoarthritis (OA). This condition affects over 30 million Americans. By harnessing each patient's own stromal vascular cells- not stem cells- GID offers a same day outpatient procedure that has shown in its phase 3 FDA IDE trial, statistical significance versus placebo, to reduce pain by 70% and improve function by 90% at one year. GID's patented disposable device isolates and concentrates over 25+ million stromal cells from a small sample of a patient's adipose tissue (fat).  Visit website.

    arrow
    David Springer

    Executive Chairman

  • GlucoModicum is developing SOFIO, a needle-free, low-cost CGM with proven proprietary technology and performance, designed for the underserved 300M people with diabetes. The company is 15 months from mass-scale commercial readiness and is currently raising €8M in equity with commitments already in place, supported by €25M in non-dilutive funding from the European Investment Bank. Visit website.

    arrow
    Jokke Maki

    Managing Director

  • Over 2 billion people suffer from chronic foot, knee, hip, or back pain—without knowing the problem starts below the ankle. Most treatments ignore the root cause: talotarsal joint instability. GraMedica fixes it at the source with a 20-minute, motion-preserving procedure that delivers 10X better outcomes—creating a scalable path to mobility, relief, and market growth. Visit website.

    arrow
    Joe Monroe

    CEO

  • GrOwnValve, a Charité and German Heart Center Berlin spin-off, is developing a breakthrough heart valve technology that uses a customized 3D-printed Mould to shape autologous tissue intra-operatively into a functioning heart valve within the operation room. The valves are mounted on a novel resorbable stent, folded for catheter-based delivery, and implanted minimally invasively. This approach fuses advanced manufacturing, smart biomaterials, and interventional cardiology to create the first durable heart valve solution for both children and adults. Visit website.

    arrow
    Boris Schmitt

    CEO

  • GuideAI Health automates the early detection of peripheral vascular disease in CT scans through advanced AI models developed by clinicians and AI/ML experts from IBM Watson Health. The platform addresses the 90% miss rate in current practice by rapidly identifying and reporting subtle disease markers, enabling early intervention before life altering complications develop through disease-to-treatment precision.  Visit website.

    arrow
    Raj Shah

    CEO

  • Gulf Medical Technologies is a medical device company developing Klens, a technology that maintains clear visualization during robotic and minimally invasive surgeries. The system prevents lens obstruction from debris, fog, and fluids, enabling surgeons to operate without workflow interruptions. In collaboration with Mayo Clinic, the company is advancing Klens with computer vision and artificial intelligence to support integration into existing surgical platforms. Visit website.

    arrow
    Ahmad Nabeel

    Founder & CEO

  • H2 Global Group is a pioneer in using molecular hydrogen in the fields of healthcare (including biotech and medtech), wellness, beauty, and veterinary medicine with patented solution for Alzheimer disease. Visit website.

    arrow
    David Marsalek

    President

  • Hadleigh Health Technologies is a medical device company focused on improving newborn and pediatric healthcare. Based in Sausalito, California, the company designs and manufactures innovative health technologies for global markets under ISO 13485 certification. Since 2015, Hadleigh has partnered with manufacturing and fulfillment teams across the U.S., Asia, Latin America, and Europe to deliver high-quality solutions for early-life care. Visit website.

    arrow
    Robert Miros

    CEO

  • Happitech has developed a CE-marked, smartphone-based method for effective remote monitoring of patients. The company's core competencies in artificial intelligence (AI) integration and photoplethysmography (PPG) enable effective and accurate measurement of heart rate and atrial fibrillation. Visit website.

    arrow
    Yosef Safi Harb

    Founder and CEO

  • HapticHeart Solutions is advancing a wearable haptic feedback platform—featuring a glove and armband—that restores tactile sensation in catheter-based, minimally invasive, and robotic procedures. By converting physical and physiological signals into real-time touch and force feedback, the system aims to enhance surgical precision, shorten learning curves, and improve patient outcomes. Currently at Technology Readiness Level 6, the prototype has demonstrated clinical utility in electrophysiology and is being expanded for use in robotic surgery.   Visit website.

    arrow
    Christopher Lee

    Co-Founder and CEO

  • HealthMosaic™ is one of the first vertically integrated healthcare platforms, functioning as a clinical AI marketplace that unifies medical devices, real-time data, and interoperable systems. It delivers full-stack AI solutions with best-in-class healthcare data, models, infrastructure, and deployment to improve outcomes across the care continuum.  

    arrow
    Justin Ramsaran

    CEO

  • The Yacoub Heart Valve: A unique, tissue-engineered valve that promises to revolutionise heart valve replacement with no compromises. Using intricate scaffold technology that transforms in-situ into a living heart valve, using the body’s own healing processes to regenerate as nature intended. Restoring full life expectancy and in kids, adapting and growing. Visit website.

    arrow
    Francis White

    CEO

  • Helico’s minimally invasive endoscopic platform uses soft robotics and AI to augment clinicians in delivering the next generation of hearing care. Its steerable balloon otoendoscope guides tools through the ear canal to hard-to-reach anatomical targets to support precision treatment delivery to the middle and inner ear. Visit website.

    arrow
    Lukas Lindenroth

    Co-founder and CEO

  • HEPTA Medical develops a minimally invasive, safe and efficient treatment for early-stage lung cancer. HEPTA Medical's device is a flexible microwave ablation probe which can be introduced through the patient's airway to provide local thermal ablation of the cancer. The company's probe employs a proprietary patented temperature sensor enabling accurate monitoring of tissue temperature in depth during the procedure and provides real-time feedback on the ablation zone to the clinician.   Visit website.

    arrow
    Thomas Bancel

    CEO

  • Hy2Care’s CartRevive® hydrogel implant is an in-situ forming hydrogel that fills cartilage defects with precision, creating a supportive matrix for natural tissue healing. It adheres to the damaged area, protects surrounding tissue, and guides healing while new cartilage forms. Visit website.

    arrow
    Sanna Severins

    COO

  • Image Navigation develops technologies to support precision and training in dental care. Its Image Guided Implantology (IGI) system uses CT scans and presurgical planning to assist with accurate dental implant placement. The company also offers DentSim, an augmented reality simulation platform designed to enhance dental education and training. Visit website.

    arrow
    Lawrence Obstfeld

    CEO

  • Implican is developing a medical device designed to improve outcomes in colorectal surgery by reducing the risk of anastomotic leakage. The Implican Anastomotic Device uses a controlled compression technique with two rings to securely connect bowel segments, promoting primary wound healing. Preclinical studies have demonstrated stable tissue connections, supporting the company’s goal of enhancing recovery for colorectal cancer patients following surgical resection. Visit website.

    arrow
    Ivo Kooijiman

    CEO

  • InFlo Medical's MOBYBOX is a portable extracorporeal membrane oxygenation (ECMO) system designed for in-hospital cardiorespiratory support with prehospital deployment capabilities. The system provides continuous extracorporeal life support across care environments, enabling patient transport and treatment without circuit interruption. Visit website.

    arrow
    Nicholas Williams

    CEO

  • InkSpace Imaging pioneers a transformative printed electronics platform, initially prioritizing advanced MRI receive coils. These lightweight and flexible coils not only elevate diagnostic imaging, revealing the once invisible, but also expedite scans, enhance patient experiences, reduce the need for sedation, and minimize procedures. Compatible with existing MRI systems and healthcare reimbursement structures, the company's FDA-cleared innovation represents a next-generation approach to accessible, high-quality diagnostics. Visit website.

  • INNITIUS develops a medical device that combines intravaginal hardware to measure cervical tissue consistency with shear elastic waves and machine learning algorithms. The device aims to provide diagnostics for multiple women’s health conditions related to childbirth timing, with dedicated algorithms for each specific indication Visit website.

    arrow
    Ruben Molina

    CEO & Co-Founder

  • Innotive Diagnostics is developing a novel bacterial infection diagnostic system to revolutionise the diagnosis of urinary tract infections (UTIs). Delivering a 99% reduction in time to result at the point of care using its diagnostic system vs. gold standard laboratory methods. Innotive’s technology is based on novel single-cell analysis that could be applicable across a range of bacterial infections. Visit website.

    arrow
    James Mainwaring

    Chief Commercial & Operating Officer

  • Inossia is developing a platform technology focused on reducing repeat fractures in patients receiving bone cement for fracture repair. The company's lead product, V-Flex, is a bone cement for vertebral augmentation that hardens at a significantly lower temperature compared to competing bone cements. The soft cement is ideal for osteoporotic bones to adjacent fracture risk without compromising on mechanical support. Visit website.

    arrow
    Malin Nilsson

    CEO

  • Interlinked is a medical technology company developing ReLink, a breakaway connector designed to reduce complications from intravenous (IV) line dislodgement. The device preserves catheter placement in situations that would normally result in removal, while also preventing fluid leakage. This approach aims to improve safety and reduce interruptions in IV therapy. Visit website.

    arrow
    Katarina Hedbeck

    CEO & Co-Founder

  • IQ Endoscopes develops single-use flexible endoscopes designed to address challenges associated with traditional reusable scopes. Their devices aim to reduce the risks of cross-contamination and eliminate the need for complex reprocessing. The company’s first-generation gastroscope, the Q Vision G-100, has received both FDA 510(k) clearance and UKCA approval. IQ Endoscopes is working towards expanding its product range to include additional gastrointestinal endoscopes by 2025. Visit website.

    arrow
    Matt Ginn

    CEO

  • Juniper Biomedical is developing a precision neuromodulation micro-implant to treat pelvic health conditions. Visit website.

    arrow
    David Constantine

    CEO

  • LEM Surgical is focused on creating and providing the next generation of robotic surgical systems. The company's flagship product, the Dynamis System, is a multi-arm robotic surgical system that incorporates novel navigation capabilities and has an open architecture for handling concentric tools. Dynamis is intended to be a platform technology for orthopedic and neurosurgical applications. Visit website.

    arrow
    Christopher Prentice

    CCO

  • Leucadia Therapeutics has developed Arethusta, an implantable medical device designed to restore cerebrospinal fluid (CSF) clearance and treat the root cause of early-stage Alzheimer’s disease and related neurodegenerative conditions. Implanted by a neurosurgeon in a minimally invasive, 30-minute outpatient procedure, Arethusta passively removes metabolite-laden CSF from the base of the brain—helping to reverse the memory and cognitive decline characteristic of early Alzheimer’s. Visit website.

    arrow
    Doug Ethell, PhD.

    Founder & CEO

  • Life Seal Vascular is developing an aneurysm sac management technology designed to reduce the incidence of Type II endoleaks following Endovascular Aneurysm Repair (EVAR). Type II endoleaks are the leading cause of reintervention after EVAR, and the Life Seal device is compatible with all EVAR systems. Currently in the pre-clinical stage, the company anticipates achieving First In Man (FIM) in Q2 of 2025. Visit website.

    arrow
    Matt Thompson, MD, FRCS

    CEO

  • LIMIS is developing PerfusiX Imaging, a dye-free surgical visualization system using Laser Speckle Contrast Imaging (LSCI) to assess tissue perfusion in real time with any existing laparoscopy tower. The company is preparing for FDA 510(k) and CE-MDR submission and is actively raising funding to accelerate certification, production and strategic integration with major MIS & RAS OEMs. Visit website.

    arrow
    Nils de Koff

    Head of Product & Operations

  • Linio Biotech is developing a first-in-kind regenerative medical device for natural tissue augmentation, leveraging its proprietary Tience® technology. Our goal is to create a paradigm shift in aesthetic medicine by replacing temporary fillers and invasive procedures with a safe, injectable product thatregenerates soft tissue — naturally and sustainably. Visit website.

    arrow
    Karita Reijonsaari

    CEO

  • Liposphere is a biomedical startup developing biocompatible, water-based nanomaterials designed to achieve ultralow friction in the human body. Spun out from the Weizmann Institute of Science, the company’s technology leverages the Hydration Lubrication Mechanism to create lubricious coatings for biological and artificial surfaces. Its platform, Coat by Liposphere, supports both pure lubrication and drug delivery applications, with investigational products like CCoat aimed at protecting cartilage surfaces in joints. Visit website.

    arrow
    Sabrina Jahn

    Co-Founder & CBO

  • Liquet Medical's mission is to transform the way vascular disease is treated. The Versus Catheter features dual tips that enables treatment of both lungs, in addition to real-time pressure monitoring sensors which allows physicians to optimize the amount of drug delivered while limiting potential side effects. Visit website. 

    arrow
    John Schindler

    CEO

  • Locate Bio is working to solve some of the most complex degenerative and infectious diseases that affect the muscular skeletal system. Locate utilises Programmed Drug Release to re-align the bioavailability of existing drugs with the underlying biological need. This bio-optimisation step has demonstrated break through improvements in performance in preclinical testing. Locate Bio is reshaping rhBMP-2 perspectives with its unique, delayed presentation of rhBMP-2. It’s lead product, LDGraft is being evaluated in a human clinical study. In a large animal model, the product has demonstrated equivalent efficacy to the gold standard, but more importantly, an excellent safety profile, with none of the adverse events reported by other studies. Visit website.

    arrow
    John von Benecke

    CEO

  • Pi is a multimodal software platform for cancer imaging and diagnostics. It is CE certified and deployed across Europe and the UK to support the analysis of MRI scans for prostate cancer, the most common cancer in men. Visit website.

    arrow
    Antony Rix

    CEO and Co-Founder

  • Lupin Dental has created an end-to-end solution to deliver beautiful and clinically excellent smiles to patients using planning software and a supervised automated robotic treatment platform. Lupin Dental’s robotic solution enables every dentist to achieve best-in-class minimally invasive tooth preparation for porcelain laminate veneers repeatably and accurately, thereby restoring the patients’ teeth following best in class aesthetic and clinical practice. Visit website.

    arrow
    Paul Roberts

    CEO

  • LuSeed's DOME is a minimally invasive device for treating bifurcation and sidewall brain aneurysms simply and effectively. The device utilizes a braided mesh design that makes it position-agnostic within the aneurysm. Another benefit of the DOME device is its design, which minimizes protrusion to the parent artery, thereby mitigating the need for dual anticoagulation therapy. Visit website.

    arrow
    Nitzan Hirsh

    Co-Founder and CEO

  • OdonAssist(tm) is a soft, inflatable device for assisting the vaginal birth of newborns, the first entirely new method to deliver newborns in hundreds of years, offering a gentle option for assisted vaginal birth designed to be safe for mothers and babies. Visit website.

    arrow
    Gary Cohen

    CEO and Co-Founder

  • May Health is developing a minimally invasive treatment for polycystic ovary syndrome (PCOS), a leading cause of female infertility due to ovulatory dysfunction. Current treatment options—including drug therapy, surgical ovarian drilling, and IVF—carry risks such as multiple pregnancies, invasiveness, and high costs. May Health’s approach aims to replicate the effectiveness of ovarian drilling while reducing procedural risk and invasiveness. The goal is to enable more natural conception pathways for women with PCOS. Visit website.

    arrow
    Colby Holtshouse

    CEO

  • Medyria has developed the PyCath, a microcatheter for full Coronary physiology targeted to therapy optimization. The PyCath awaits FDA clearance and will be launched in US in 2026. Visit website.

    arrow
    Mauro Sette

    CEO

  • Methinks vision is to provide universal and timely medical assistance to enable life-saving treatments worldwide. The company is initially focused on stroke, the second most common cause of death and a major cause of disability globally. Its AI software, Methinks Stroke Suite, is capable of assisting in stroke triage and providing decision support for life-saving treatment using the simplest medical imaging (non-contrast CT), with the potential to optimize stroke triage and reduce time to treatment. Visit website.

    arrow
    Pau Rodriguez

    CEO

  • MicroSteer develops a robotic platform, enabling controlled navigation and manipulation of standard endoscopic instruments. The technology is designed to integrate with existing endoscopes to facilitate en-bloc resection of large or flat gastrointestinal polyps through precise, semi-automated tissue dissection. Visit website.

    arrow
    Eyal Ben-Esti

    CEO

  • Microsure’s MUSA robot enables microsurgeons to perform sub-millimeter anastomosis for patients who - for example - had to undergo breast amputation or suffer from lymphedema. Visit website.

    arrow
    Iwan van Vijfeijken

    CEO

  • myBiometry is a platform technology to remotely monitor and manage patients with chronic conditions. The initial application for the company's technology will be asthma. Through a combination of machine learning, a proprietary single-use sensor and measurement device, the company is collecting and monitoring biomarker data to understand treatment efficacy, adherence, and risk of costly asthma attacks. Visit website.

    arrow
    Bryan Nolan

    CEO

  • Nano4Imaging has developed an magnetic resonance (MR) compatible guidewire to transfer select cardiovascular procedures from the cathlab to the MRI suite. Initially focused on developing their solutions for congenital heart diseases, the company plans to expand their technology into interventional procedures, such as angioplasty. Visit website.

    arrow
    Rudolf Schulze Vohren

    CEO

  • Nanoflex Robotics is developing next-generation, remote robotic solutions to enhance access to life-saving procedures. The company's robotic system uses advanced magnetic technology and ultra-flexible endoluminal tools to enable faster and easier navigation through tortuous blood vessels. Nanoflex's initial target application aims to shorten the time to treatment for acute ischemic stroke by making remote mechanical thrombectomies a reality. Visit website.

    arrow
    Matt Curran

    CEO

  • NeoCor develops the CoApt Valve®, a transcatheter device designed to treat severe mitral and tricuspid valve disease through a minimally invasive approach. The CoApt Valve features a self-expanding nitinol frame and an electrospun polymeric valve, aiming to reduce or eliminate regurgitant jets without the need for open-heart surgery. The device is delivered via a catheter inserted through the transfemoral vein, preserving the native valve structure. CoApt Valve is advancing its technology through preclinical studies in both canine and human models, with plans to initiate veterinary clinical trials.​ Visit website.

    arrow
    George Kramer

    Founder & CEO

  • NeoPredics develops advanced predictive clinical decision support solutions using machine learning and AI algorithms to assess maternal and neonatal health risks. Their primary focus is on early detection of conditions such as preeclampsia and jaundice, providing data-driven insights to improve outcomes in high-risk pregnancies and newborn care. Visit website.

    arrow
    Thorsten Waloschek

    CEO

  • Neuroelectrics unlocks the power of computational neuroscience to treat brain disorders. Pioneering non-invasive tech for personalized neuromodulation, aiming to restore brain health & improve lives. Visit website.

    arrow
    Ana Maiques

    CEO & co-founder

  • New Phase is advancing cancer treatment through a proprietary nanotechnology platform designed to improve outcomes for patients with stage IV cancer. The company’s approach uses biocompatible, multicore superparamagnetic iron oxide nanoparticles delivered to tumor tissue and activated by an alternating magnetic field to induce localized hyperthermia. By heating cancer cells to 50°C, this method selectively destroys tumors while sparing healthy tissue, aiming to extend life and preserve quality of life. Visit website.

    arrow
    Irie Meltzer

    VP Business Development

  • Newronika's AlphaDBS is a closed-loop deep brain neuromodulation system. The device interprets the bioelectrical neuronal activity (local field potentials, LFPs) in the brain areas where stimulation is delivered and accordingly adapts moment-by-moment the stimulation to follow patient’s clinical condition. The technology is being developed as a treatment for Parkinson's disease. Visit website.

    arrow
    Keith Carlton

    Executive Chairman

  • Newrotex, based in Oxford, UK is a clinical-stage startup redefining nerve repair with the first viable silk-based device for large-gap injuries. Our flagship product, SilkAxonsTM, solves the massive unmet need for an effective, scalable, large-gap peripheral nerve repair device —an untapped, multi-billion-pound market. Visit website.

    arrow
    Alex Woods

    Founder, CEO

  •  NewUro, with Bay Area partner Stellartech Research Corporation, has developed Uzap: a single-session, transurethral, drug-free and implant-free RF therapy for overactive bladder (OAB).   Following a $2M NIH Fast-Track award, the system is now first-in-human-ready. We have applied for a $3M NIH Phase IIB continuation grant and are seeking additional funding to address the therapy gap in the multibillion dollar OAB market. Visit website.

    arrow
    Itzhak Avneri, MD

    CEO

  • NIMBLE is developing a first-in-class, non-invasive, non-ionizing system to monitor coronary stent health using microwave-based technology. Designed to detect occlusion, fracture, or migration, the NIMBLE System provides cardiologists with objective data on stent status—without relying on invasive angiograms. With over 4 million stents implanted annually and a 30% failure rate within two years, NIMBLE addresses an $8B market with the goal of improving outcomes and saving lives. Visit website.

    arrow
    Oriol Iborra

    CEO & Co-Founder

  • Nitinotes develops the EndoZip™, the first fully automated endoscopic suturing system for Endoscopic Sleeve Gastroplasty (ESG), a minimally invasive weight-loss procedure. Designed for efficiency, EndoZip enables a single-operator ESG procedure with automated, standardized suturing, reducing variability, procedure time, and training requirements. The system facilitates outpatient treatment with low-risk and predictable outcomes, addressing the growing need for effective, non-surgical obesity interventions. Visit website.

    arrow
    Lloyd Diamond

    CEO

  • Njord is a medtech spin-off from Sahlgrenska University Hospital with a mission to solve unmet needs in radiology and patient handling. The first product launched is a novel patient transfer device (co-bot solution) Atle® 180 enabling improved efficiency and quality of care for acute care departments. The solution is already in use by +30 hospitals in Northern Europe. Visit website. 

    arrow
    Jacob Ahrnstein

    CEO & Co-founder

  • Noah Labs Vox eliminates the no. 1 cause of hospital admissions - congestive heart failure - 2 weeks before hospitalization by analyzing voice changes caused by fluid build-up in the lungs and vocal tract. Trained on the world's largest heart failure voice data set, the patented technology is being piloted at Mayo Clinic, UCSF and Charité Berlin.  Visit website.

    arrow
    Oliver Piepenstock

    CEO & Co-Founder

  • Nordstar Medical has developed a patented single-handed deployment device: a novel peripheral nerve block catheter (PNBC) designed for insertion before or after surgery to deliver local anaesthetic directly to targeted nerves. Rooted in nearly two decades of clinical research, this technology represents the first opioid-free, high-usability solution for managing postsurgical pain. Addressing a $56.5 billion global postoperative pain market, Nordstar is focused on U.S. and European orthopedic and anesthesia departments to improve recovery and reduce hospital length of stay (LOS) costs. Visit website.

    arrow
    Tore Allerup, MD

    Co-founder and CEO

  • Severe infections still claim a huge number of lives, to date 11 million per year. This is partially caused by the limitations of current diagnostic methods, which are often slow and fail to identify the causative pathogens. As a consequence, clinicians have to rely on untargeted, broad-spectrum therapy which can be inadequate or associated with negative side-effects for the patient. Noscendo addresses this critical need with DISQVER® which leverages next-generation sequencing (NGS) of cell-free DNA, isolated from blood samples, to precisely identify 16.000 microbes and parasites.  Visit website.

    arrow
    Andreas Kapplein

    CEO

  • Nostics is developing point-of-care diagnostics that combine Raman spectroscopy, nanotechnology, and artificial intelligence to enable rapid pathogen identification. By detecting the molecular fingerprint of microorganisms, Nostics provides fast, affordable testing to support appropriate antimicrobial use and improve health outcomes. The platform’s AI-based classifier can be quickly adapted to recognize new pathogens, offering scalable solutions for global diagnostic needs. Visit website.

    arrow
    Eva Rennen

    Co-Founder & COO

  • Novuson’s patented DTU technology will represent the first substantive innovation in over 25 years for targeting vessel sealing / dividing, and hemostasis (bleeding control) in surgical and trauma applications. Visit website.

    arrow
    Stuart Mitchell

    CEO

  • Nuri is the first emotion brain-computer interface (eBCI) built for psychiatry, with initial focus on severe, treatment-resistant PTSD. Our implantable, therapeutic Deep Brain Recoding (DBR) system detects, decodes and retrains dysfunctional emotion circuits according to each patient's neural signature - delivering relief where conventional treatments fail.  Visit website.

    arrow
    Dan Rappaport

    CEO

  • Nyxoah is a medical technology company developing innovative neuromodulation therapies for obstructive sleep apnea (OSA). Its lead product, Genio, is a battery-free, minimally invasive hypoglossal nerve stimulation device implanted through a single incision and controlled by a wearable. Designed as an alternative to CPAP therapy, Genio has demonstrated best-in-class outcomes for reducing OSA burden. Nyxoah aims to transform sleep health for the over one billion people affected by OSA worldwide. Visit website.

    arrow
    Olivier Taelman

    CEO

  • ORTHOSON’S Bio-Structural technology: injectable, anatomy-sparing cellular scaffold, combined with immediate mechanical restoration. Visit website.

    arrow
    Rich Simmonds

    CEO

  • Osteal Therapeutics is a musculoskeletal therapeutics company developing solutions for the treatment of orthopedic infections. The company's lead product, VT-X7, is a drug-device combination that utilizes high concentrations of vancomycin and tobramycin, in conjunction with a drug delivery system, to irrigate infected joint spaces as a result of periprosthetic joint infection in joint replacement patients.  Visit website.

    arrow
    David Thompson

    CEO

  • Panda Surgical, a University College London spinout, is introducing the world's smallest robotics and AI platform for minimally invasive neurosurgery, offering surgeons enhanced dexterity and decision-support to make these operations safer, more effective, and more widely adopted. Visit website.

    arrow
    Manios Dimitrakakis

    CEO

  • PanTher Therapeutics is a clinical-stage oncology company developing its Sagittari platform, a localized, polymer-based drug delivery system that enables sustained high-dose cancer therapy directly at tumor sites while minimizing systemic side effects. Visit website.

    arrow
    Laura Indolfi

    CEO

  • Paradromics is building the world’s most capable and clinically viable brain-computer interface (BCI) platform. Its advanced neurotechnology captures brain activity at the highest resolution, individual neurons, enabling AI-powered treatments for motor impairment, chronic pain, addiction, depression, and other neurological conditions. The company's first clinical product, Connexus® BCI, is designed to restore speech and communication for people who are unable to speak due to debilitating motor conditions.  Visit website.

    arrow
    Matt Angle

    Founder and CEO

  • Peerbridge Health is a digital health company advancing cardiac care through AI-driven ambulatory ECG monitoring. Its flagship device, the Peerbridge Cor, is a patented 3-lead, 2-channel wireless AECG patch designed on Einthoven’s Triangle to replicate 12-lead Holter quality. The device captures 31 rhythms with exceptional signal fidelity, enabling rapid and remote heart failure diagnosis in as little as 30 minutes. By combining proprietary algorithms with high-resolution ECG recordings, Peerbridge Health offers a more accessible and efficient alternative to in-hospital screening for patients with chronic cardiovascular conditions. Visit website.

    arrow
    Chris Darland

    CEO

  • Perfuze develops catheter-based technology for the treatment of acute ischemic stroke. The Millipede System enables efficient clot removal via an extra-large lumen aspiration catheter designed to maximize first pass success. The company recently completed its U.S. pivotal IDE study and has raised €54 million to date. Visit website.

    arrow
    Wayne Allen

    CEO

  • Needle-free jet injection technology, proven for vaccine and therapeutic delivery, with appropriate clinical claims and regulatory approvals for intradermal and intramuscular tissues, now expanding into subcutaneous chronic disease indications with new platforms.   Visit website.

    arrow
    Heather Potters

    EVP, Co-Founder

  • PharmaSens is developing the world’s first patch for automated insulin therapy — integrating insulin infusion and continuous glucose monitoring in one device. Our solution will radically simplify diabetes management and cut costs by more than 50% compared to current options. Visit website.

    arrow
    Marcel Both

    CEO

  • Pixee Medical develops augmented reality solutions for implant placement that offer orthopedic surgeons cutting-edge and clinically proven tools for precise and efficient surgery. Its first generation Kneeᐩ technology has already been used in over 10,000 procedures in more than 20 countries, demonstrating its positive impact on surgical practices worldwide. Visit website.

    arrow
    Sebastien Henry

    CEO

  • Planatome is a patented technology platform, adapted from semiconductor manufacturing and licensed to industry leaders to create the world’s most advanced surgical cutting instruments – think semiconductor meets medical. Visit website.

    arrow
    Tim Tobin

    CEO

  • Plexāā is a UK-based MedTech company developing innovative solutions to improve surgical outcomes. Its flagship device, BLOOM⁴³, is a fully wearable system designed to precondition the skin before breast surgery by gently warming the area to stimulate the release of Heat Shock Proteins, which improve blood flow and support healing. Clinical trials have shown that this approach can reduce wound healing complications such as infection and skin necrosis. Plexāā is also investigating applications of this technology in other surgical areas including obstetrics, orthopedics, and vascular surgery. Visit website.

    arrow
    Gaele Lalahy

    COO

  • Polarean’s Xenon MRI platform, now commercially available in the United States for patients six years and older, uses the first and only FDA-approved inhaled contrast agent (XENOVIEW®) to provide functional lung imaging that visualizes regional ventilation and gas exchange without radiation. The platform integrates with MRI systems from GE HealthCare, Philips, and Siemens Healthineers, supporting earlier diagnosis, treatment planning, and monitoring of lung diseases. It also serves as a sensitive tool for drug development, enabling quantitative assessment of therapeutic response. Visit website.

    arrow
    Christopher von Jako, PhD

    CEO

  • Precision Cardiovascular is focused on enhancing the outcomes and quality of life for patients with heart failure. The company is developing a miniature sensor that is placed in the pulmonary artery to continuously collect and analyze data to improve the remote management of cardiovascular diseases. Visit website.

    arrow
    Mohamed Abou-Alam

    CEO

  • EASEE is Precisis' neurostimulation device that can act in two modes - excitatory and inhibitory. The duality of the device allows its to be used for the treatment of many cerebral diseases, including epilepsy, depression, and cognitive disfunctions caused by stroke. Precisis is currently developing a close-loop system for their EASEE technology, which will allow the device to record brain activity and respond with targeted stimulation. Visit website.

    arrow
    Karl Stoklosa

    CEO

  • PBM-HALE™ is a non-invasive, contamination-free deep lung sample collection device. It enables clinicians and researchers to obtain distal lung fluid for laboratory analysis without procedures such as bronchoscopy or sputum induction. The samples can be used in clinical and research settings to investigate disease mechanisms, validate new diagnostics, and monitor treatment response, creating pathways to better patient outcomes across a wide range of respiratory conditions. Visit website.

    arrow
    Sterghios Moschos

    Founder/Chief Executive Officer

  • Quantanosis.ai is developing a portable, AI-powered stroke detection and treatment platform that is non-invasive, operator-independent, and capable of enabling diagnosis and intervention in under two minutes. Visit website.

    arrow
    Yousef Khalili

    Co-founder

  • QuantiLight develops an In-vitro Diagnostic platform for Therapeutic Drug Monitoring from home. Fueled by bioluminescent sensor technology from the Max-Planck-Institute for Medical Research, we provide actionable blood test results in just 15 minutes. Our secure app empowers chronic patients and healthcare professionals, reducing hospital visits and environmental impact, while saving costs to the healthcare system. Visit website.

    arrow
    Corentin Gondrand

    CEO

  • RebrAIn is a medical technology company focused on improving Deep Brain Stimulation (DBS) and brain lesion surgeries for Parkinson’s disease and essential tremor. Its platform uses supervised AI algorithms and a collaborative health data registry to accurately identify brain regions targeted for treatment. By standardizing and streamlining pre-surgical planning, RebrAIn integrates AI-guided targeting into neurosurgical workflows to support greater precision and consistency in patient care. Visit website.

    arrow
    David Caumartin

    CEO

  • Refined Laser Systems is a biophotonics company developing stain-free, molecular-specific microscopy technology that delivers H&E-equivalent tissue diagnostics within minutes to support faster, more reliable cancer surgery and treatment decisions. Visit website.

    arrow
    Max Brinkmann

    Business Development

  • ReGelTec, Inc. is a clinical stage medical device company developing the next generation of interventional spinal implants for chronic lower back pain due to degenerative disc disease. Hydrafil is a Injectable hydrogel for Degenerative Disc Disease the procedure has a very short recovery time 1-2 hrs post injection with early clinical results showing significant improvement in back pain and ODI scores. Visit website.

    arrow
    Bill Niland

    CEO

  • Rekovar develops wearable biosensor technology aimed at improving the management of Neonatal Abstinence Syndrome (NAS). Its flagship product, NeoMonki, is an investigational neonatal monitoring kit designed to provide real-time, objective data on infants' physiological and behavioral states. The system includes a wristband sensor, imaging camera, tablet application, and a provider portal, enabling healthcare professionals to deliver personalized care and intervention. Visit website.

    arrow
    Shiva Sharareh

    CEO

  • Relief Srl is an innovative Italian MedTech company developing a first-in-class device for the treatment of stress urinary incontinence (SUI). Visit website.

    arrow
    Gioia Lucarini

    CEO and Co-Founder

  • Resolve Stroke’s vision is to transform neurodiagnosis from a complex, delayed process into one that is rapid and reliable at the point of care. Its software suite converts raw ultrasound data into neurovascular biomarkers, enabling earlier and more accurate diagnosis in time-critical settings. This biomarker platform defines a new diagnostic category and creates scalable licensing opportunities with OEMs and healthcare providers. Visit website.

    arrow
    Aritz Zamacola

    cofounder and CEO

  • RespirAI is developing a wearable platform that passively monitors physiological data to support long-term patient care. Originating from research at the University of Nebraska Omaha, the system uses a novel bio-coupling marker to measure synchronization between breathing and walking—enabling early detection of COPD exacerbations. Its algorithm integrates artificial intelligence to enhance predictive accuracy, helping patients, families, and clinicians anticipate changes in respiratory health. Visit website.

    arrow
    Nimrod Bin-Nun

    Co-founder & CEO

  • Retia develops healthtech AI algorithms for helping guide management of surgical and critically ill patients to improve outcomes. This is a $4 billion market. The company's technology has been clinically validated and is used in 65 hospitals.  Visit website.

    arrow
    Marc Zemel

    CEO

  • ReVision Implant is developing the world's first prosthesis that restores useful vision to blind people. We are using implants with thousands of microelectrodes and advanced stimulation algorithms to directly transmit video to the visual cortex of the brain. Visit website.

    arrow
    Frederik Ceyssens

    co-founder & CEO

  • Rob Surgical has developed Bitrack, a portable surgical robotic system designed for use across multiple operating rooms and hospitals. Its compatibility with standard ORs and pay-per-use model eliminate the need for dedicated infrastructure or high procedural volumes, enabling broader access to robotic surgery in underserved markets. Visit website.

    arrow
    Mario Ferradosa

    CEO & General Manager

  • SamanTree Medical's Histolog Scanner is a digital microscopy scanner for high-resolution imaging of the surface of fresh tissue. The device utilizes novel, ultra-fast confocal microscopy technology to enable rapid histological assessment in the operating room or pathology laboratory.  Visit website.

    arrow
    Olivier Delporte

    CEO

  • Scalpel AI builds a connected surgical intelligence platform with AI-driven systems for the surgical supply chain and sterile services, focusing on instrument recognition, tray validation, and workflow automation. Their technology helps hospitals, orthopedic and spine device companies, distributors, and sterile processing divisions to reduce errors, streamline logistics, and improve instrument readiness. Visit website.

    arrow
    Dr. Yeshwanth Pulijala

    Founder & CEO

  • ScienceForBrain is developing a medical technology designed to protect brain function during cardiac bypass surgeries and neuro-intensive care. Built on over 30 years of research and multiple patents, the system enables heart-lung machines to generate regular rectangular blood flow pulsations, allowing real-time assessment of cerebral autoregulation. This capability helps clinicians maintain optimal brain perfusion tailored to each patient, with the aim of reducing postoperative complications such as delirium and cognitive decline. Visit website.

    arrow
    Tad Svendrys

    Chief Operating Officer

  • Seerlinq is the first certified medical device to offer non-invasive, cost-effective monitoring of cardiac filling pressure from home. The telemonitoring service can detect heart failure decompensation up to 30 days in advance, helping to prevent hospitalizations and deaths using just a simple oximeter or smartwatch. Seerlinq has been shown to reduce hospitalizations by up to 80%, making it one of the most effective non-invasive interventions. Already reimbursed and in clinical use across Slovakia, Seerlinq is now entering the German market and partnering with a leading smartwatch brand to scale heart failure diagnostics and monitoring globally. Visit website.

    arrow
    Allan Bohm

    CEO

  • Transforming the experience for both patient and clinician in interventional procedures with a 3D augmented reality platform featuring real-time holographic visualization of the patient’s actual anatomy, “floating” over the patient. Visit website.

    arrow
    Berk Tas

    CEO

  • Sequana Medical NV develops technologies to treat diuretic-resistant fluid overload in liver disease, heart failure, and cancer. Its alfapump device, approved by the FDA as a breakthrough and PMA-approved, is a fully implantable pump that automatically moves excess fluid to the bladder for natural excretion, targeting recurrent ascites from liver cirrhosis. Sequana Medical is also advancing DSR, a phase IIa drug program aimed at treating diuretic resistance and cardiorenal syndrome in heart failure. Both technologies address large and growing markets driven by increasing disease prevalence. Visit website.

    arrow
    Ian Crosbie

    CEO

  • Serox is developing low-cost, non-invasive IVDs for high-incidence diseases at the point of care. By combining Raman Spectroscopy, Surface Enhanced Raman Spectroscopy (SERS), and machine learning, Serox enables the detection of cancers and infections in urine without the need for invasive procedures like blood draws or cystoscopy. The company is initially focused on bladder, prostate, and kidney cancers, with plans to expand into women’s cancers and urinary tract infection diagnostics. Serox’s technology aims to streamline screening and reduce unnecessary interventions through fast, accurate, and personalized urine-based testing. Visit website.

    arrow
    Mark Evans

    CFO

  • Shape Memory Medical is focused on innovative, therapeutic solutions for endovascular markets with its proprietary shape memory polymers (SMP). SMP is a bioabsorbable polyurethane embolic scaffold that supports rapid conversion to organized thrombus followed by tissue ingrowth. With commercialized devices in peripheral vascular embolization space, the company is actively leveraging its platform technology to develop novel applications for the management of complex aortic pathologies including aortic aneurysms. Visit website.

    arrow
    Edward “Ted” Ruppel

    President and CEO

  • SitnStand is a mobility technology company focused on enhancing independence for individuals with limited strength or mobility. The company’s flagship product is a personal lift assistant that helps users safely and confidently transition between sitting and standing. Designed for use at home or on the go, SitnStand offers a practical solution for maintaining autonomy without relying on caregivers.  Visit website.

    arrow
    Gal Goldner

    CEO

  • SmartCardia, a Swiss med-tech company has developed a next-generation 7-lead ECG and vitals patch and cloud platform for real-time cardiac and remote patient monitoring. With FDA and CE approvals, proprietary AI for arrhythmia detection, and a U.S. diagnostic facility enabling reimbursement, the company is positioned for rapid global growth. Visit website.

    arrow
    Srinivasan Murali

    CEO

  • Solaris Endovascular, Inc. is a growth stage, US-based medical device company developing advanced endovascular solutions for patients suffering from dialysis access challenges and Peripheral Artery Disease. With a proven stent platform and innovative drug-eluting technology, led by seasoned executives with extensive experience in cardiovascular MedTech, Solaris Endovascular is uniquely positioned and committed to improving long-term patient outcomes and transforming vascular health. Visit website.

    arrow
    Randy Hubbell

    President & CEO

  • Solenic Medical is developing a non-invasive medical device that utilizes alternating magnetic fields to eradicate biofilms that form on implants. The company's platform uses external magnetic coils to destroy infective biofilms on the surface of knee and hip replacement implants, as well as plates and rods for trauma related procedures. Solenic's solution is being developed to replace the expensive and risky two-step revision surgery, which is the current standard of care for chronic infections on medical implants. Visit website.

    arrow
    Bart Bandy

    CEO

  • SonicPrecision is developing a dual-source RF and PFA ablation catheter with integrated ultrasound sensors that enable real-time monitoring and visualization for safer, more precise treatment of cardiac arrhythmias. Visit website.

    arrow
    Rene Aarnink

    CEO

  • Sonion Health is developing a biosensing digital health platform for cuffless blood pressure monitoring, addressing hypertension as a major risk factor for cardiovascular mortality. The technology has been developed over several years by Sonion engineers, known for their expertise in balanced armature receivers, premium microphones, and electromechanical devices. This platform aims to enhance hypertension management through continuous, non-invasive monitoring.

    arrow
    Jim Fidacaro

    Executive Vice President, Sonion & CEO

  • The first osseointegrative biomimetic knee cartilage implant. Visit website.

    arrow
    Dimitrios Angelis

    Co-Founder

  • SpinaFX is bridging the therapeutic gap in the treatment of back and leg pain caused by a contained herniated disc. The company has pioneered a minimally invasive, image-guided treatment that injects a mixture of oxygen and ozone gas to reduce a single level herniation. Clinical data shows that the solution leads to a reduction of disc volume, which relieves nerve root compression to alleviate pain. Visit website.

    arrow
    Jeff Cambra

    CEO

  • Spinally is developing an intrathecal spinal cord stimulation and recording system that significantly improves on existing neuromodulation solutions. Unlike conventional products, Spinally’s technology offers superior spatial precision and deeper stimulation capabilities while consuming less power. It also enables high-fidelity neuronal signal recording, supporting closed-loop approach. The device is designed for rapid deployment using a micro-needle insertion method, which simplifies the surgical process and minimizes patient recovery time. Our initial focus is chronic pain. However, the system's design and performance open opportunities across a broader range of therapeutic applications: Parkinson’s disease, neurorehabilitation, and spine-computer interface, creating a path toward treating complex neurological conditions with greater specificity and adaptability. Visit website.

    arrow
    Pawel Soluch

    CEO

  • StarTric’s mission is to advance and transform the treatment of tricuspid regurgitation, a serious and significantly undertreated heart valve disease. Building on the scientific and clinical foundation of a proven surgical technique, the company is developing TriClover—a transcatheter device designed to deliver a safe, effective, and minimally invasive solution for a broad range of patients, including those ineligible for open-heart surgery or current transcatheter therapies. Visit website.

    arrow
    Eugenio Passanante

    Co-founder & CFO

  • STENTiT is developing a novel class of regenerative implants, solely composed from resorbable fibers. The balloon expandable implant provides instant structural support to keep the artery open, while allowing circulating blood cells to infiltrate into the porous mesh. This triggers a natural healing response by which immune cells gradually replace the mesh with new vascular tissue as the implant safely dissolves over time. Hereby, the RFS fully reconstructs the artery from the inside out. In addition, the fibrillated design allows to be scaled beyond 100 mm to serve the majority patient population. Visit website.

    arrow
    Bart Sanders

    CEO & Founder

  • Surfix is developing a photonic diagnostics platform that combines a nanocoated biochip, microfluidic cartridge, and desktop reader to deliver rapid, high-precision point-of-care protein detection with expansion potential for molecular testing. Visit website.

    arrow
    Jos Lunenberg

    CEO

  • SurgiBox Inc. develops technology to improve surgical safety for both patients and healthcare providers, particularly in resource-limited settings. The company’s flagship product, SurgiBox, is designed to reduce intraoperative contamination of incisions while minimizing provider exposure to bodily fluids and aerosols. SurgiBox redefines surgical safety by focusing protection on the surgical field rather than the entire operating room. The company continues to develop a pipeline of products aimed at enabling safe and efficient surgical care in diverse environments. Visit website.

    arrow
    Mike Teodorescu

    CEO

  • Synseer is a wearables company developing biometric devices designed to help users better manage their personal health and wellness. Its flagship product, HealthBuds, are in-ear devices that simultaneously track hearing and heart health to deliver continuous, high-accuracy vital sign data. Supported by an AI-powered wellness assistant, HealthBuds translate body signals into actionable insights, helping users take a proactive approach to their health—simply by wearing earbuds. Visit website.

    arrow
    John Martino

    Founder, CEO

  • Tempo Therapeutics is a San Diego-based biotechnology company advancing tissue engineering through its proprietary MAP (Microporous Annealed Particle) material science technology. The platform enables the in vivo formation of functional tissue and organs and supports the development of next-generation vaccines that are shelf-stable and multivalent. MAP scaffolds are fully synthetic, minimally invasive, and designed to evade immune rejection while promoting a pro-regenerative immune response. Tempo’s mission is to use MAP to help define the future of medicine. Visit website.

    arrow
    Westbrook Weaver

    CEO

  • Tensive is a biomedical startup, which develops innovative scaffolds aiming to offer a natural breast reconstruction or augmentation. Tensive’s long-term mission is to restore a natural breast to patients, who experienced reconstructive surgery after mastectomy or lumpectomy, to improve their quality of life and avoiding recurrent and expensive surgical operations. Visit website.

    arrow
    Sanjay Kakkar

    CEO

  • The BioSport™ is an AI-powered, multi-omics platform that merges genetics, biomarkers, and wearable data to optimize athletic performance and safety. Its unique BioFit™ Score, analyzing 15,000+ sport-related variants, delivers hyper-personalized training, nutrition, and recovery plans. Athletes and coaches gain data-driven real-time insights via The BioSport interactive App to enhance results, reduce injury risk, and unlock peak potential. Visit website.

    arrow
    Raman Kapoor

    Chief Healthspan Officer and BioGut

  • The Insides Company is a first-in-class medtech company providing breakthrough therapeutic devices for intestinal failure patients. Visit website.

    arrow
    Garth Sutherland

    CEO

  • ThinkSono Guidance enables any non-ultrasound trained healthcare professional to scan for blood clots (DVT). It reduces waiting times, negative DVT cases and can be used at the point of care. Visit website.

    arrow
    Fouad Noor

    CEO

  • Titanium Textiles AG is the first company worldwide producing elastic titanium for medical applications, usually implants. Based on a broad medical device registration in a major country there are many studies available and thousands of patients were treated with excellent results. The production technology is proprietary and the company has a significant number of issued application patents. The technology will substitute many products so far based on Polypropylene. Visit website.

    arrow
    Christoph Ehlers

    President & Founder

  • TFO - Tricuspid Flow Optimizer A Novel Transcatheter System for Minimally Invasive Treatment of Tricuspid Regurgitation Visit website.

    arrow
    Stéphane Piat

    Chairman of the Board

  • TYBR Health is developing a natural hydrogel to prevent adhesions (internal scarring) that can occur following minimally invasive surgery. The technology is intended to reduce post-operative complications which can cause patients pain and require rehabilitation following tendon and joint surgeries.  Visit website.

    arrow
    Tim Keane

    Co-Founder & CEO

  • Cultivating brain health therapy through continuous, ultra-long-term EEG monitoring and transformative real-world data. Our MDR CE-approved 24/7 EEG SubQ solution captures subcutaneous brain activity to deliver actionable insights that empower clinicians and researchers to personalize treatment and reduce uncontrolled seizures in epilepsy. By harnessing AI and big data, we are unlocking new possibilities in digital biomarkers, drug development, and neuromodulation. Visit website.

    arrow
    Martin Stenfeldt

    CEO

  • VACERE Medical’s feasibility trial in vasospasm subjects reduced the rate of death and disability from a U.S. national average of 50% — to 0%.  Equally impressive: CT imaging in each study subject confirmed “on-command” (i) enhanced perfusion and (ii) vasodilation.  VACERE intends to pursue accelerated clearance in vasospasm and commence revenue, while gathering data to demonstrate prophylactic (and non-invasive!) elimination of cerebral vasospasm as a disease state.   FDA granted an IDE for the emergency treatment of ischemic stroke patients, which VACERE will also pursue. Please talk with us about joining our fight against cerebral vasospasm and stroke!  See the two-minute video at vacere.com. Visit website.

    arrow
    Jeffrey Lietzke

    CEO

  • Vascular Perfusion Solutions specializes in the development of technologies to enhance the preservation of organs. The VP.S ENCORE device is designed to extend the viability of organs for transplantation beyond the current standard of care. The device consists of a single-use disposable unit that operates with a non-blood, nutrient-rich solution. VPS is currently focused on developing the device for use in heart transplantation, with plans to modify the device for the preservation of other organs, ex vivo therapies, and organ banking.  Visit website.

    arrow
    Rafael J. Veraza

    CEO & President

  • Vena Vitals is an early stage med-tech company focused on non-invasive continuous blood pressure monitoring. The company's proprietary technology is a soft flexible sensor that conforms to the skin for direct pressure measurement at theradial artery. The company's technology is intended to replace unnecessarily invasive arterial line measurements as well as non-continuous cuff-based methods in both the hospital and at home. Visit website.

    arrow
    Ray Liu

    CEO & Co-Founder

  • With the rapid growth of large-bore transcatheter procedures such as TMVR, TTVR, and leadless pacemaker implantations, there is a critical unmet need for safe, effective, and time-saving vascular closure solutions. Venock addresses this gap with a proprietary vascular closure device capable of closing access sites as large as the vessel diameter itself (20-30F and larger).  Venock device features a novel, staple-based mechanism that is quick and easy to deploy, and without any complicated preparation steps. Visit website.

    arrow
    Wolfgang Goetz

    Founder

  • Our novel pVAD technology is the most powerful and smallest pVAD technology that we know, able to provide over 7L/min at physiological pressures and provide total left ventricular support for cardiogenic shock and other critically ill patients. Total support has been shown to reduce infarct size for heart attack patients, and the recent DanGer shock trial has validated the use of pVAD technology in cardiogenic shock patients. The technology is based on 7 granted patents and no catheter or sheath larger than 9Fr is used in the percutaneous, Cath lab, implant procedure.  Visit website.

    arrow
    Martin Cook

    CEO and co-founder

  • Versono is developing an intravascular ultrasonic platform to improve the crossing of severe occlusions in the peripheral vasculature. The device will prepare a working lumen to support endovascular therapy in patients with chronic total occlusions (CTOs) and critical limb ischemia (CLI). Visit website.

    arrow
    Finbar Dolan

    CEO

  • The VESTECK, "SUTURE-TIGHT"tm endovascular catheter is a platform technology that comes preloaded with nitinol sutures.  Our initial target market is improving the durability of implants in the $7B aortic repair space.  Improving implant durability for patients, providing better results for clinicians and reduced costs for the global health care system. Visit website.

    arrow
    Joseph Rafferty

    CEO and Founder

  • ViCentra is a commercial-stage company redefining wearable insulin delivery with Kaleido, the smallest, lightest, and most accurate insulin patch pump in its class. Designed to empower rather than remind users of their chronic condition, Kaleido combines consumer-grade aesthetics with clinical precision—discreet, customizable, and built for real life. Integrated with Diabeloop’s CE-marked closed loop algorithm, Kaleido enables fully automated insulin therapy. ViCentra is actively scaling manufacturing to meet surging demand, with more than 3,200 users across Germany, France, and the Netherlands and a goal of reaching over 12,000 users by the end of 2026. The company is headquartered in Utrecht, The Netherlands, and is preparing for U.S. market entry in 2027. Visit website.

    arrow
    Tom Arnold

    CEO

  • VirtaMed develops mixed-reality surgical simulators designed to enhance medical education and improve patient outcomes. Its platforms integrate real surgical instruments with haptic feedback and photorealistic graphics to provide immersive training experiences across specialties such as orthopedics, obstetrics and gynecology, urology, and general surgery. VirtaMed also offers customizable training solutions for medical device companies and educational institutions, supported by its cloud-based platform, VirtaMed Connect, for performance tracking and curriculum development. The company is headquartered in Zurich, Switzerland, with additional locations in the United States and China. Visit website.

    arrow
    Raimundo Sierra

    CEO & Co-Founder

  • A spin-out from the University of Oxford, Vivid Dx is a precision diagnostics company transforming pathogen detection and antimicrobial resistance (AMR). The company is developing a next-generation platform to deliver broad pathogen ID in 30 minutes and phenotypic antibiotic susceptibility testing (AST) in 3 hours – directly from blood, with no blood culture required. By combining novel pathogen cell isolation, Raman spectroscopy, a proprietary Raman spectra database, and advanced AI/ML, the platform has the potential to redefine the speed, accuracy, and clinical utility of infectious disease diagnostics. The company is backed by Oxford Science Enterprises and other leading investors. Visit website.

    arrow
    John Sperzel

    CEO

  • Wellumio is a venture-backed company specializing in portable MRI solutions for acute neuroimaging applications. The company’s core enabling technology is a novel pulse-gradient free nuclear magnetic resonance sensor platform with an initial focus on acute stroke triage and diagnosis. Visit website.

    arrow
    Dr Shieak Tzeng

    Co-founder & CEO

  • Wellvii is a digital health company focused on improving patient care through innovative remote monitoring solutions. Its flagship product, the Wellvii BP Go, is a cuffless, portable blood pressure monitor that makes tracking heart health simple, comfortable, and accurate. By seamlessly connecting patients and providers through real-time data, BP Go helps improve compliance, early detection, and long-term health outcomes. Visit website.

    arrow
    Mark Khachaturian

    CEO

  • WISE S.p.A. is developing next-generation electrodes for neuromonitoring, neuromodulation, and brain-machine interfaces using its proprietary Supersonic Technology. The company’s portfolio includes the FDA-cleared WISE Cortical Strip for intraoperative monitoring and the Heron® lead, the first percutaneous directional lead for spinal cord stimulation. WISE’s thin, flexible electrodes offer superior neural tissue conformity and minimal invasiveness. These innovations aim to disrupt the $3B SCS market and advance care across multiple neuro applications. Visit website.

    arrow
    Luca Ravagnan

    CEO

  • Xeltis' bioabsorbable devices, made of bioabsorbable polymers that are structured as porous matrices through electrospinning, are designed to work as valves or vessels once implanted, and to allow ETR as the body's natural healing process pervades them with components of native tissue, including collagen, endothelial lining and capillary blood vessels, which normally develop and organize themselves into natural functioning tissue. The matrices are structured to be absorbed overtime, to leave patients with new, healthy, functioning valves or vessels. Visit website.

    arrow
    Eliane Schutte

    CEO

  • Yaqrit is developing an extracorporeal liver support system aimed at critically ill patients with multiple organ failures. The system removes blood toxins and replaces dysfunctional albumin to support recovery from acute-on-chronic liver failure (ACLF). Clinical data indicates a 67% improvement in patient outcomes over 10 days. Visit website.

    arrow
    Troels Jordansen

    CEO

  • YourHeartCheck provides Direct to Consumer ECG Holter analysis and develops technology that combines continuous ECG monitoring with algorithms capable of estimating blood pressure every ten heartbeats. Over a standard 72-hour Holter recording, this produces approximately 24,000 blood pressure data points, providing a detailed picture of cardiovascular behaviour alongside rhythm analysis. Visit website.

    arrow
    Chris Crockford

    Founder

  • Zedsen’s mission is to provide safe, affordable, reliable breast health screening for all women. Our low cost, non-radiating, compact hardware, combined with AI-enabled analysis, makes this possible. Zedsen’s technology not only provides cancer screening, but can also assess breast density, allowing women to avoid inappropriate follow up screening.  Non-radiating tech means women can get assessed as often as they like, greatly improving early detection rates, empowering women to safely and regularly monitor their breast health.  Visit website.

    arrow
    Alexander Antrobus

    CEO

  • Zepto Life Technology is developing a next-generation molecular diagnostics platform that leverages Nobel Prize-winning Giant Magnetoresistance (GMR) technology to deliver rapid, ultra-sensitive, and multiplexed detection of infectious diseases. The company aims to transform diagnostic standards by enabling high-precision, point-of-care testing with faster turnaround times than traditional methods. In addition to its core platform, Zepto operates diagnostic labs and provides CRO services to support FDA submissions and commercialization for other diagnostic developers. Visit website.

    arrow
    Hannah Zhang

    CEO

  • ZygoFix develops and commercializes its zLOCK system, a proprietary technology that adds "bend-ability" to joints and provide natural stabilization. The technology is currently used to achieve spinal fusion and spinal stability without screws.  Visit website.

    arrow
    Ofer Levy

    CEO

our next summit
Apply to Present at LSI USA '26
LSI USA is the true epicenter of medtech. In 2025, the summit convened
over 1,700, with 75 panel and keynote sessions, 375 presenting startups,
and 350 active investors and decision-makers from top VC and PE funds,
CVCs, family offices, accelerators, angel groups and more.
Apply to Present at LSI USA ‘26  Revisit LSI USA '25 
lsi logo
Contact Us Customer Login

Upcoming Events

LSI USA ‘26
March 16-20, 2026
Dana Point, CA
LSI ASIA ‘26
June 30 - July 2, 2026
Singapore
LSI EUROPE ‘26
Sept 28 - Oct 1, 2026
Barcelona

More From LSI

Resources

17011 Beach Blvd, Suite 500 Huntington Beach, CA 92647

714-847-3540

© 2025 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy